activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2144711	CHEMBL934581	Inhibition of TAK1	B	COC(=O)c1c(-c2ccccc2)c2cc(Br)ccc2c(=O)n1Cc1ccc(S(C)(=O)=O)cc1		CHEMBL259060	>	IC50	nM	11000.0	CHEMBL5776	Homo sapiens	IC50	nM	11000.0
	2144711	CHEMBL934581	Inhibition of TAK1	B	COC(=O)c1c(-c2ccccc2)c2cc(Br)ccc2c(=O)n1Cc1ccc(S(C)(=O)=O)cc1		CHEMBL259060	>	IC50	nM	11000.0	CHEMBL5776	Homo sapiens	IC50	nM	11000.0
	2144715	CHEMBL935466	Inhibition of TAK1 at 10 uM	B	COC(=O)c1c(-c2ccccc2)c2cc(Br)ccc2c(=O)n1Cc1ccc(S(C)(=O)=O)cc1		CHEMBL259060	=	Inhibition	%	12.0	CHEMBL5776	Homo sapiens	Inhibition	%	12.0
	2147398	CHEMBL922184	Activity of human TAK1 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	111.0	CHEMBL5776	Homo sapiens	Activity	%	111.0
	2248197	CHEMBL1012680	Inhibition of c-TAK1 at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	5.0	CHEMBL5776	Homo sapiens	INH	%	5.0
	2248227	CHEMBL1012680	Inhibition of c-TAK1 at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	2356991	CHEMBL958287	Inhibition of TAK1 at 1 uM relative to control	B	Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL525893	>	Inhibition	%	50.0	CHEMBL5776	Homo sapiens	INH	%	50.0
	2511609	CHEMBL973463	Inhibition of TAK1	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	35.0	CHEMBL5776	Homo sapiens	IC50	uM	0.035
	2639169	CHEMBL1025475	Inhibition of MAP3K7	B	O[C@H]1CC[C@H](Nc2ccc3nnc(-c4cccc(C(F)(F)F)c4)n3n2)CC1		CHEMBL494221	>	Ki	nM	4000.0	CHEMBL5776	Homo sapiens	Ki	nM	4000.0
Not Determined	2639170	CHEMBL1025475	Inhibition of MAP3K7	B	FC(F)(F)c1cccc(-c2nnc3ccc(NC4CCNCC4)nn23)c1		CHEMBL493169		Ki			CHEMBL5776	Homo sapiens	Ki		
	2691875	CHEMBL1054699	Inhibition of human TAK1 assessed as remaining activity at 10 uM	B	Cc1ccccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL551717	=	Activity	%	111.0	CHEMBL5776	Homo sapiens	Activity	%	111.0
	2721730	CHEMBL1053575	Inhibition of TAK1 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL5776	Homo sapiens	INH	%	50.0
	2922011	CHEMBL1059370	Inhibition of TAK1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	84.0	CHEMBL5776	Homo sapiens	Activity	%	84.0
	2938419	CHEMBL1038672	Inhibition of TAK1	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Ki	nM	3000.0	CHEMBL5776	Homo sapiens	Ki	uM	3.0
	3332167	CHEMBL1167715	Inhibition of TAK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5776	Homo sapiens	INH	%	50.0
	3333582	CHEMBL1167715	Inhibition of TAK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5776	Homo sapiens	INH	%	50.0
	3334987	CHEMBL1167715	Inhibition of TAK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5776	Homo sapiens	INH	%	50.0
	3336407	CHEMBL1167715	Inhibition of TAK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5776	Homo sapiens	INH	%	50.0
	3341949	CHEMBL1167715	Inhibition of TAK1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5776	Homo sapiens	INH	%	50.0
	3343396	CHEMBL1167715	Inhibition of TAK1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5776	Homo sapiens	INH	%	50.0
	3351773	CHEMBL1175029	Inhibition of TAK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.25	CHEMBL5776	Homo sapiens	INH	%	0.25
	3358825	CHEMBL1175029	Inhibition of TAK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.2	CHEMBL5776	Homo sapiens	INH	%	0.2
	3445008	CHEMBL1244993	Binding affinity to TAK1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	8500.0	CHEMBL5776	Homo sapiens	Kd	nM	8500.0
	3448640	CHEMBL1244993	Binding affinity to TAK1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	uM	10.0
	3448797	CHEMBL1244993	Binding affinity to TAK1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	2.9	CHEMBL5776	Homo sapiens	Kd	nM	2.9
	3449058	CHEMBL1244993	Binding affinity to TAK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	130.0	CHEMBL5776	Homo sapiens	Kd	nM	130.0
	3449353	CHEMBL1244993	Binding affinity to TAK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	93.0	CHEMBL5776	Homo sapiens	Kd	nM	93.0
	3449354	CHEMBL1244993	Binding affinity to TAK1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	690.0	CHEMBL5776	Homo sapiens	Kd	nM	690.0
	3449355	CHEMBL1244993	Binding affinity to TAK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	720.0	CHEMBL5776	Homo sapiens	Kd	nM	720.0
	5120266	CHEMBL1646662	Inhibition of human TAK1 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	89.0	CHEMBL5776	Homo sapiens	INH	%	89.0
	5243773	CHEMBL1685877	Inhibition of TAK1 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	84.0	CHEMBL5776	Homo sapiens	INH	%	84.0
	5243881	CHEMBL1686093	Inhibition of TAK1 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	35.0	CHEMBL5776	Homo sapiens	INH	%	35.0
	5243994	CHEMBL1685877	Inhibition of TAK1 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	73.0	CHEMBL5776	Homo sapiens	INH	%	73.0
	5244102	CHEMBL1686093	Inhibition of TAK1 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	9.0	CHEMBL5776	Homo sapiens	INH	%	9.0
	5244975	CHEMBL1685877	Inhibition of TAK1 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	73.0	CHEMBL5776	Homo sapiens	INH	%	73.0
	5245083	CHEMBL1686093	Inhibition of TAK1 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	24.0	CHEMBL5776	Homo sapiens	INH	%	24.0
	5245234	CHEMBL1685877	Inhibition of TAK1 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	114.0	CHEMBL5776	Homo sapiens	INH	%	114.0
	5246064	CHEMBL1686093	Inhibition of TAK1 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	112.0	CHEMBL5776	Homo sapiens	INH	%	112.0
	6153412	CHEMBL1763407	Competitive inhibition of TAK1 overexpressed in Hela cells assessed as TAK1 autophosphorylation on Thr187 by ELISA in presence of 25 uM ATP	B	O=C1Nc2ccccc2/C1=N/N=C1\SCC(=O)N1c1ccc(O)cc1		CHEMBL1761585	=	TC50	uM	11.0	CHEMBL5776	Homo sapiens	TC50	uM	11.0
	6167679	CHEMBL1769220	Inhibition of TAK1	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	=	Ki	nM	860.0	CHEMBL5776	Homo sapiens	Ki	uM	0.86
	6180253	CHEMBL1772642	Inhibition of TAK1 assessed as residual activity of enzyme at 10 uM	B	Cc1cc(N/N=C/c2ccncc2)nc2ccccc12		CHEMBL1771411	=	Activity	%	68.0	CHEMBL5776	Homo sapiens	Activity	%	68.0
	6180254	CHEMBL1772643	Inhibition of TAK1 assessed as residual activity of enzyme at 25 uM	B	Cc1cc(N/N=C/c2ccncc2)nc2ccccc12		CHEMBL1771411	=	Activity	%	48.0	CHEMBL5776	Homo sapiens	Activity	%	48.0
	6339917	CHEMBL1826215	Activity of TAK1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	69.0	CHEMBL5776	Homo sapiens	Activity	%	69.0
	6352282	CHEMBL1826259	Inhibition of TAK1 assessed as residual activity at 10 uM by radioactivity assay in presence of 5 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	53.0	CHEMBL5776	Homo sapiens	Activity	%	53.0
	7567129	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	650.0	CHEMBL5776	Homo sapiens	Kd	nM	650.0
	7567588	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7568059	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7568527	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7568959	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	100.0	CHEMBL5776	Homo sapiens	Kd	nM	100.0
	7569102	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7569562	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7570034	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7570497	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	5300.0	CHEMBL5776	Homo sapiens	Kd	nM	5300.0
	7570924	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	93.0	CHEMBL5776	Homo sapiens	Kd	nM	93.0
	7571078	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7571535	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	1800.0	CHEMBL5776	Homo sapiens	Kd	nM	1800.0
	7572011	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	730.0	CHEMBL5776	Homo sapiens	Kd	nM	730.0
	7573059	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7573516	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	3700.0	CHEMBL5776	Homo sapiens	Kd	nM	3700.0
	7573992	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	7.2	CHEMBL5776	Homo sapiens	Kd	nM	7.2
	7574019	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7574427	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	160.0	CHEMBL5776	Homo sapiens	Kd	nM	160.0
	7575037	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	4.1	CHEMBL5776	Homo sapiens	Kd	nM	4.1
	7575498	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7575992	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	130.0	CHEMBL5776	Homo sapiens	Kd	nM	130.0
	7576400	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	2300.0	CHEMBL5776	Homo sapiens	Kd	nM	2300.0
	7577011	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7577506	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7577976	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7578381	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	3100.0	CHEMBL5776	Homo sapiens	Kd	nM	3100.0
	7579401	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	540.0	CHEMBL5776	Homo sapiens	Kd	nM	540.0
	7579875	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	36.0	CHEMBL5776	Homo sapiens	Kd	nM	36.0
	7580344	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	1600.0	CHEMBL5776	Homo sapiens	Kd	nM	1600.0
	7580747	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7580935	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	640.0	CHEMBL5776	Homo sapiens	Kd	nM	640.0
	7581320	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	150.0	CHEMBL5776	Homo sapiens	Kd	nM	150.0
	7581765	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	2900.0	CHEMBL5776	Homo sapiens	Kd	nM	2900.0
	7582236	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7582700	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7583100	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	2300.0	CHEMBL5776	Homo sapiens	Kd	nM	2300.0
	7583281	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7583678	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7584123	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7584594	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7585056	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	49.0	CHEMBL5776	Homo sapiens	Kd	nM	49.0
	7585460	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7585611	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7586019	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	1400.0	CHEMBL5776	Homo sapiens	Kd	nM	1400.0
	7586465	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7586936	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7587390	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7587572	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	8500.0	CHEMBL5776	Homo sapiens	Kd	nM	8500.0
	7587991	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7588444	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7588915	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7589537	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7589961	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	2.9	CHEMBL5776	Homo sapiens	Kd	nM	2.9
	7590428	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	4700.0	CHEMBL5776	Homo sapiens	Kd	nM	4700.0
	7590911	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7591510	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	1300.0	CHEMBL5776	Homo sapiens	Kd	nM	1300.0
	7591932	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	630.0	CHEMBL5776	Homo sapiens	Kd	nM	630.0
	7592435	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7592888	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7593477	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1.5	CHEMBL5776	Homo sapiens	Kd	nM	1.5
	7593912	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	490.0	CHEMBL5776	Homo sapiens	Kd	nM	490.0
	7593942	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7594415	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7594867	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	100.0	CHEMBL5776	Homo sapiens	Kd	nM	100.0
	7595445	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7595921	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7596392	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7596839	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	690.0	CHEMBL5776	Homo sapiens	Kd	nM	690.0
	7597428	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	3300.0	CHEMBL5776	Homo sapiens	Kd	nM	3300.0
	7597901	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7598371	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5776	Homo sapiens	Kd	nM	10000.0
	7598813	CHEMBL1908421	Binding constant for TAK1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	67.0	CHEMBL5776	Homo sapiens	Kd	nM	67.0
	7922664	CHEMBL1918889	Inhibition of human recombinant TAK1 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	72.0	CHEMBL5776	Homo sapiens	INH	%	72.0
	7969801	CHEMBL1930373	Inhibition of TAK1 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	96.0	CHEMBL5776	Homo sapiens	Activity	%	96.0
	8009703	CHEMBL1941378	Inhibition of TAK1 at 1 uM	B	NC(=O)c1cnc(N)c2cc(-c3ccc(N4CCOCC4)cc3)sc12		CHEMBL1938642	>	Inhibition	%	90.0	CHEMBL5776	Homo sapiens	INH	%	90.0
	10842344	CHEMBL2013789	Inhibition of MAP3K7	B	O=c1[nH]nc2cc(CO)c3ccc(-c4ccc[nH]4)cc3n12		CHEMBL2012881	=	IC50	nM	650.0	CHEMBL5776	Homo sapiens	IC50	nM	650.0
	10984760	CHEMBL2072056	Inhibition of human TAK1 at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	<	Inhibition	%	50.0	CHEMBL5776	Homo sapiens	INH	%	50.0
	12036434	CHEMBL2150268	Inhibition of N-terminal FLAG-tagged TAK1 expressed in baculovirus after 5 mins by scintillation counter	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	>	IC50	nM	10000.0	CHEMBL5776	Homo sapiens	IC50	nM	10000.0
	12170728	CHEMBL2214636	Inhibition of TAK1 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	108.0	CHEMBL5776	Homo sapiens	Activity	%	108.0
	12170859	CHEMBL2212726	Inhibition of TAK1 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	101.0	CHEMBL5776	Homo sapiens	Activity	%	101.0
	12172190	CHEMBL2209682	Inhibition of TAK1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	59.0	CHEMBL5776	Homo sapiens	Activity	%	59.0
	12188404	CHEMBL2211125	Binding affinity to TAk1 at 1 uM	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	<	Activity	%	50.0	CHEMBL5776	Homo sapiens	Activity	%	50.0
	12265414	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	104.0	CHEMBL5776	Homo sapiens	Residual Activity	%	104.0
	12265415	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	93.0	CHEMBL5776	Homo sapiens	Residual Activity	%	93.0
	12265416	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	95.0	CHEMBL5776	Homo sapiens	Residual Activity	%	95.0
	12265417	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	98.0	CHEMBL5776	Homo sapiens	Residual Activity	%	98.0
	12265418	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	91.0	CHEMBL5776	Homo sapiens	Residual Activity	%	91.0
	12265419	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	89.0	CHEMBL5776	Homo sapiens	Residual Activity	%	89.0
	12265420	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	92.0	CHEMBL5776	Homo sapiens	Residual Activity	%	92.0
	12265421	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	100.0	CHEMBL5776	Homo sapiens	Residual Activity	%	100.0
	12265422	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	96.0	CHEMBL5776	Homo sapiens	Residual Activity	%	96.0
	12265423	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	98.0	CHEMBL5776	Homo sapiens	Residual Activity	%	98.0
	12265424	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	91.0	CHEMBL5776	Homo sapiens	Residual Activity	%	91.0
	12265425	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	78.0	CHEMBL5776	Homo sapiens	Residual Activity	%	78.0
	12265426	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	92.0	CHEMBL5776	Homo sapiens	Residual Activity	%	92.0
	12265427	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	86.0	CHEMBL5776	Homo sapiens	Residual Activity	%	86.0
	12265428	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	78.0	CHEMBL5776	Homo sapiens	Residual Activity	%	78.0
	12265429	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	89.0	CHEMBL5776	Homo sapiens	Residual Activity	%	89.0
	12265430	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	100.0	CHEMBL5776	Homo sapiens	Residual Activity	%	100.0
	12265431	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	92.0	CHEMBL5776	Homo sapiens	Residual Activity	%	92.0
	12265432	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	86.0	CHEMBL5776	Homo sapiens	Residual Activity	%	86.0
	12265433	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	44.0	CHEMBL5776	Homo sapiens	Residual Activity	%	44.0
	12265434	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	83.0	CHEMBL5776	Homo sapiens	Residual Activity	%	83.0
	12265435	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	83.0	CHEMBL5776	Homo sapiens	Residual Activity	%	83.0
	12265436	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	92.0	CHEMBL5776	Homo sapiens	Residual Activity	%	92.0
	12265437	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	98.0	CHEMBL5776	Homo sapiens	Residual Activity	%	98.0
	12265438	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	98.0	CHEMBL5776	Homo sapiens	Residual Activity	%	98.0
	12265439	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	95.0	CHEMBL5776	Homo sapiens	Residual Activity	%	95.0
	12265440	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	62.0	CHEMBL5776	Homo sapiens	Residual Activity	%	62.0
	12265441	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	81.0	CHEMBL5776	Homo sapiens	Residual Activity	%	81.0
	12265442	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	85.0	CHEMBL5776	Homo sapiens	Residual Activity	%	85.0
	12265443	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	86.0	CHEMBL5776	Homo sapiens	Residual Activity	%	86.0
	12265444	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	91.0	CHEMBL5776	Homo sapiens	Residual Activity	%	91.0
	12265445	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	91.0	CHEMBL5776	Homo sapiens	Residual Activity	%	91.0
	12265446	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	97.0	CHEMBL5776	Homo sapiens	Residual Activity	%	97.0
	12265447	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	93.0	CHEMBL5776	Homo sapiens	Residual Activity	%	93.0
	12265448	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	88.0	CHEMBL5776	Homo sapiens	Residual Activity	%	88.0
	12265449	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	87.0	CHEMBL5776	Homo sapiens	Residual Activity	%	87.0
	12265450	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	84.0	CHEMBL5776	Homo sapiens	Residual Activity	%	84.0
	12265451	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	89.0	CHEMBL5776	Homo sapiens	Residual Activity	%	89.0
	12265452	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	89.0	CHEMBL5776	Homo sapiens	Residual Activity	%	89.0
	12265453	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	94.0	CHEMBL5776	Homo sapiens	Residual Activity	%	94.0
	12265454	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	97.0	CHEMBL5776	Homo sapiens	Residual Activity	%	97.0
	12265455	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	93.0	CHEMBL5776	Homo sapiens	Residual Activity	%	93.0
	12265456	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	59.0	CHEMBL5776	Homo sapiens	Residual Activity	%	59.0
	12265457	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	10.0	CHEMBL5776	Homo sapiens	Residual Activity	%	10.0
	12265458	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	87.0	CHEMBL5776	Homo sapiens	Residual Activity	%	87.0
	12265459	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	85.0	CHEMBL5776	Homo sapiens	Residual Activity	%	85.0
	12265460	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	91.0	CHEMBL5776	Homo sapiens	Residual Activity	%	91.0
	12265461	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	76.0	CHEMBL5776	Homo sapiens	Residual Activity	%	76.0
	12265462	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	99.0	CHEMBL5776	Homo sapiens	Residual Activity	%	99.0
	12265463	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	99.0	CHEMBL5776	Homo sapiens	Residual Activity	%	99.0
	12265464	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	82.0	CHEMBL5776	Homo sapiens	Residual Activity	%	82.0
	12265465	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	86.0	CHEMBL5776	Homo sapiens	Residual Activity	%	86.0
	12265466	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	16.0	CHEMBL5776	Homo sapiens	Residual Activity	%	16.0
	12265467	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	88.0	CHEMBL5776	Homo sapiens	Residual Activity	%	88.0
	12265468	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	94.0	CHEMBL5776	Homo sapiens	Residual Activity	%	94.0
	12265469	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	99.0	CHEMBL5776	Homo sapiens	Residual Activity	%	99.0
	12265470	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	107.0	CHEMBL5776	Homo sapiens	Residual Activity	%	107.0
	12265471	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	97.0	CHEMBL5776	Homo sapiens	Residual Activity	%	97.0
	12265472	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	88.0	CHEMBL5776	Homo sapiens	Residual Activity	%	88.0
	12265473	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	88.0	CHEMBL5776	Homo sapiens	Residual Activity	%	88.0
	12265474	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	83.0	CHEMBL5776	Homo sapiens	Residual Activity	%	83.0
	12267122	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	39.0	CHEMBL5776	Homo sapiens	Residual Activity	%	39.0
	12267123	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	102.0	CHEMBL5776	Homo sapiens	Residual Activity	%	102.0
	12267124	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	100.0	CHEMBL5776	Homo sapiens	Residual Activity	%	100.0
	12267125	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	104.0	CHEMBL5776	Homo sapiens	Residual Activity	%	104.0
	12267126	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	100.0	CHEMBL5776	Homo sapiens	Residual Activity	%	100.0
	12267127	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	96.0	CHEMBL5776	Homo sapiens	Residual Activity	%	96.0
	12267128	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	95.0	CHEMBL5776	Homo sapiens	Residual Activity	%	95.0
	12267129	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	94.0	CHEMBL5776	Homo sapiens	Residual Activity	%	94.0
	12267130	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	96.0	CHEMBL5776	Homo sapiens	Residual Activity	%	96.0
	12267131	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	96.0	CHEMBL5776	Homo sapiens	Residual Activity	%	96.0
	12267132	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	105.0	CHEMBL5776	Homo sapiens	Residual Activity	%	105.0
	12267133	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	103.0	CHEMBL5776	Homo sapiens	Residual Activity	%	103.0
	12267134	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	99.0	CHEMBL5776	Homo sapiens	Residual Activity	%	99.0
	12267135	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	99.0	CHEMBL5776	Homo sapiens	Residual Activity	%	99.0
	12267136	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	88.0	CHEMBL5776	Homo sapiens	Residual Activity	%	88.0
	12267137	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	96.0	CHEMBL5776	Homo sapiens	Residual Activity	%	96.0
	12267138	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	4.0	CHEMBL5776	Homo sapiens	Residual Activity	%	4.0
	12267139	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	98.0	CHEMBL5776	Homo sapiens	Residual Activity	%	98.0
	12267140	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	14.0	CHEMBL5776	Homo sapiens	Residual Activity	%	14.0
	12267141	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	99.0	CHEMBL5776	Homo sapiens	Residual Activity	%	99.0
	12267142	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	82.0	CHEMBL5776	Homo sapiens	Residual Activity	%	82.0
	12267143	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	94.0	CHEMBL5776	Homo sapiens	Residual Activity	%	94.0
	12267144	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	109.0	CHEMBL5776	Homo sapiens	Residual Activity	%	109.0
	12267145	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	100.0	CHEMBL5776	Homo sapiens	Residual Activity	%	100.0
	12267146	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	93.0	CHEMBL5776	Homo sapiens	Residual Activity	%	93.0
	12267147	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	101.0	CHEMBL5776	Homo sapiens	Residual Activity	%	101.0
	12267148	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	106.0	CHEMBL5776	Homo sapiens	Residual Activity	%	106.0
	12267149	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	101.0	CHEMBL5776	Homo sapiens	Residual Activity	%	101.0
	12267150	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	64.0	CHEMBL5776	Homo sapiens	Residual Activity	%	64.0
	12267151	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	95.0	CHEMBL5776	Homo sapiens	Residual Activity	%	95.0
	12267152	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	90.0	CHEMBL5776	Homo sapiens	Residual Activity	%	90.0
	12267153	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	67.0	CHEMBL5776	Homo sapiens	Residual Activity	%	67.0
	12267154	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	95.0	CHEMBL5776	Homo sapiens	Residual Activity	%	95.0
	12267155	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	106.0	CHEMBL5776	Homo sapiens	Residual Activity	%	106.0
	12267156	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	103.0	CHEMBL5776	Homo sapiens	Residual Activity	%	103.0
	12267157	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	102.0	CHEMBL5776	Homo sapiens	Residual Activity	%	102.0
	12267158	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	96.0	CHEMBL5776	Homo sapiens	Residual Activity	%	96.0
	12267159	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	86.0	CHEMBL5776	Homo sapiens	Residual Activity	%	86.0
	12267160	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	87.0	CHEMBL5776	Homo sapiens	Residual Activity	%	87.0
	12267161	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	55.0	CHEMBL5776	Homo sapiens	Residual Activity	%	55.0
	12267162	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	-1.0	CHEMBL5776	Homo sapiens	Residual Activity	%	-1.0
	12267163	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	101.0	CHEMBL5776	Homo sapiens	Residual Activity	%	101.0
	12267164	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	88.0	CHEMBL5776	Homo sapiens	Residual Activity	%	88.0
	12267165	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	84.0	CHEMBL5776	Homo sapiens	Residual Activity	%	84.0
	12267166	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	96.0	CHEMBL5776	Homo sapiens	Residual Activity	%	96.0
	12267167	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	91.0	CHEMBL5776	Homo sapiens	Residual Activity	%	91.0
	12267168	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	93.0	CHEMBL5776	Homo sapiens	Residual Activity	%	93.0
	12267169	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	92.0	CHEMBL5776	Homo sapiens	Residual Activity	%	92.0
	12267170	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	81.0	CHEMBL5776	Homo sapiens	Residual Activity	%	81.0
	12267171	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	104.0	CHEMBL5776	Homo sapiens	Residual Activity	%	104.0
	12267172	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	103.0	CHEMBL5776	Homo sapiens	Residual Activity	%	103.0
	12267173	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	57.0	CHEMBL5776	Homo sapiens	Residual Activity	%	57.0
	12267174	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	99.0	CHEMBL5776	Homo sapiens	Residual Activity	%	99.0
	12267175	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	92.0	CHEMBL5776	Homo sapiens	Residual Activity	%	92.0
	12267176	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	85.0	CHEMBL5776	Homo sapiens	Residual Activity	%	85.0
	12267177	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	48.0	CHEMBL5776	Homo sapiens	Residual Activity	%	48.0
	12267178	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	93.0	CHEMBL5776	Homo sapiens	Residual Activity	%	93.0
	12267179	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	101.0	CHEMBL5776	Homo sapiens	Residual Activity	%	101.0
	12267180	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	112.0	CHEMBL5776	Homo sapiens	Residual Activity	%	112.0
	12267181	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	90.0	CHEMBL5776	Homo sapiens	Residual Activity	%	90.0
	12267182	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	89.0	CHEMBL5776	Homo sapiens	Residual Activity	%	89.0
	12267183	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	77.0	CHEMBL5776	Homo sapiens	Residual Activity	%	77.0
	12267184	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	83.0	CHEMBL5776	Homo sapiens	Residual Activity	%	83.0
	12267185	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	36.0	CHEMBL5776	Homo sapiens	Residual Activity	%	36.0
	12267186	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	94.0	CHEMBL5776	Homo sapiens	Residual Activity	%	94.0
	12267187	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	73.0	CHEMBL5776	Homo sapiens	Residual Activity	%	73.0
	12267188	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	112.0	CHEMBL5776	Homo sapiens	Residual Activity	%	112.0
	12267189	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	98.0	CHEMBL5776	Homo sapiens	Residual Activity	%	98.0
	12267190	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	9.0	CHEMBL5776	Homo sapiens	Residual Activity	%	9.0
	12267191	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	92.0	CHEMBL5776	Homo sapiens	Residual Activity	%	92.0
	12267192	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	92.0	CHEMBL5776	Homo sapiens	Residual Activity	%	92.0
	12267193	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	41.0	CHEMBL5776	Homo sapiens	Residual Activity	%	41.0
	12267194	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	94.0	CHEMBL5776	Homo sapiens	Residual Activity	%	94.0
	12267195	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	48.0	CHEMBL5776	Homo sapiens	Residual Activity	%	48.0
	12267196	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	85.0	CHEMBL5776	Homo sapiens	Residual Activity	%	85.0
	12267197	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	91.0	CHEMBL5776	Homo sapiens	Residual Activity	%	91.0
	12267198	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	47.0	CHEMBL5776	Homo sapiens	Residual Activity	%	47.0
	12267199	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	89.0	CHEMBL5776	Homo sapiens	Residual Activity	%	89.0
	12267200	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	87.0	CHEMBL5776	Homo sapiens	Residual Activity	%	87.0
	12267201	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	101.0	CHEMBL5776	Homo sapiens	Residual Activity	%	101.0
	12267202	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	100.0	CHEMBL5776	Homo sapiens	Residual Activity	%	100.0
	12267203	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	89.0	CHEMBL5776	Homo sapiens	Residual Activity	%	89.0
	12267204	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	57.0	CHEMBL5776	Homo sapiens	Residual Activity	%	57.0
	12267205	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	95.0	CHEMBL5776	Homo sapiens	Residual Activity	%	95.0
	12267206	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	97.0	CHEMBL5776	Homo sapiens	Residual Activity	%	97.0
	12267207	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	91.0	CHEMBL5776	Homo sapiens	Residual Activity	%	91.0
	12267208	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	90.0	CHEMBL5776	Homo sapiens	Residual Activity	%	90.0
	12267209	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	91.0	CHEMBL5776	Homo sapiens	Residual Activity	%	91.0
	12267210	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	106.0	CHEMBL5776	Homo sapiens	Residual Activity	%	106.0
	12267211	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	75.0	CHEMBL5776	Homo sapiens	Residual Activity	%	75.0
	12267212	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	107.0	CHEMBL5776	Homo sapiens	Residual Activity	%	107.0
	12267213	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	105.0	CHEMBL5776	Homo sapiens	Residual Activity	%	105.0
	12267214	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	94.0	CHEMBL5776	Homo sapiens	Residual Activity	%	94.0
	12267215	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	107.0	CHEMBL5776	Homo sapiens	Residual Activity	%	107.0
	12267216	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	92.0	CHEMBL5776	Homo sapiens	Residual Activity	%	92.0
	12267217	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	104.0	CHEMBL5776	Homo sapiens	Residual Activity	%	104.0
	12267218	CHEMBL2219197	Millipore: Percentage of residual kinase activity of MAP3K7 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	112.0	CHEMBL5776	Homo sapiens	Residual Activity	%	112.0
	12267219	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	103.0	CHEMBL5776	Homo sapiens	Residual Activity	%	103.0
	12267220	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	75.0	CHEMBL5776	Homo sapiens	Residual Activity	%	75.0
	12267221	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	95.0	CHEMBL5776	Homo sapiens	Residual Activity	%	95.0
	12267222	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	95.0	CHEMBL5776	Homo sapiens	Residual Activity	%	95.0
	12267223	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	90.0	CHEMBL5776	Homo sapiens	Residual Activity	%	90.0
	12267224	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	88.0	CHEMBL5776	Homo sapiens	Residual Activity	%	88.0
	12267225	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	77.0	CHEMBL5776	Homo sapiens	Residual Activity	%	77.0
	12267226	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	91.0	CHEMBL5776	Homo sapiens	Residual Activity	%	91.0
	12267227	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	100.0	CHEMBL5776	Homo sapiens	Residual Activity	%	100.0
	12267228	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	106.0	CHEMBL5776	Homo sapiens	Residual Activity	%	106.0
	12267229	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	96.0	CHEMBL5776	Homo sapiens	Residual Activity	%	96.0
	12267230	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	74.0	CHEMBL5776	Homo sapiens	Residual Activity	%	74.0
	12267231	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	90.0	CHEMBL5776	Homo sapiens	Residual Activity	%	90.0
	12267232	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	78.0	CHEMBL5776	Homo sapiens	Residual Activity	%	78.0
	12267233	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	25.0	CHEMBL5776	Homo sapiens	Residual Activity	%	25.0
	12267234	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	98.0	CHEMBL5776	Homo sapiens	Residual Activity	%	98.0
	12267235	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	102.0	CHEMBL5776	Homo sapiens	Residual Activity	%	102.0
	12267236	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	94.0	CHEMBL5776	Homo sapiens	Residual Activity	%	94.0
	12267237	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	86.0	CHEMBL5776	Homo sapiens	Residual Activity	%	86.0
	12267238	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	62.0	CHEMBL5776	Homo sapiens	Residual Activity	%	62.0
	12267239	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	87.0	CHEMBL5776	Homo sapiens	Residual Activity	%	87.0
	12267240	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	83.0	CHEMBL5776	Homo sapiens	Residual Activity	%	83.0
	12267241	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	90.0	CHEMBL5776	Homo sapiens	Residual Activity	%	90.0
	12267242	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	92.0	CHEMBL5776	Homo sapiens	Residual Activity	%	92.0
	12267243	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	100.0	CHEMBL5776	Homo sapiens	Residual Activity	%	100.0
	12267244	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	83.0	CHEMBL5776	Homo sapiens	Residual Activity	%	83.0
	12267245	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	23.0	CHEMBL5776	Homo sapiens	Residual Activity	%	23.0
	12267246	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	62.0	CHEMBL5776	Homo sapiens	Residual Activity	%	62.0
	12267247	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	82.0	CHEMBL5776	Homo sapiens	Residual Activity	%	82.0
	12267248	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	66.0	CHEMBL5776	Homo sapiens	Residual Activity	%	66.0
	12267249	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	71.0	CHEMBL5776	Homo sapiens	Residual Activity	%	71.0
	12267250	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	88.0	CHEMBL5776	Homo sapiens	Residual Activity	%	88.0
	12267251	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	96.0	CHEMBL5776	Homo sapiens	Residual Activity	%	96.0
	12267252	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	90.0	CHEMBL5776	Homo sapiens	Residual Activity	%	90.0
	12267253	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	86.0	CHEMBL5776	Homo sapiens	Residual Activity	%	86.0
	12267254	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	86.0	CHEMBL5776	Homo sapiens	Residual Activity	%	86.0
	12267255	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	78.0	CHEMBL5776	Homo sapiens	Residual Activity	%	78.0
	12267256	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	82.0	CHEMBL5776	Homo sapiens	Residual Activity	%	82.0
	12267257	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	90.0	CHEMBL5776	Homo sapiens	Residual Activity	%	90.0
	12267258	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	87.0	CHEMBL5776	Homo sapiens	Residual Activity	%	87.0
	12267259	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	90.0	CHEMBL5776	Homo sapiens	Residual Activity	%	90.0
	12267260	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	90.0	CHEMBL5776	Homo sapiens	Residual Activity	%	90.0
	12267261	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	57.0	CHEMBL5776	Homo sapiens	Residual Activity	%	57.0
	12267262	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	-2.0	CHEMBL5776	Homo sapiens	Residual Activity	%	-2.0
	12267263	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	87.0	CHEMBL5776	Homo sapiens	Residual Activity	%	87.0
	12267264	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	85.0	CHEMBL5776	Homo sapiens	Residual Activity	%	85.0
	12267265	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	94.0	CHEMBL5776	Homo sapiens	Residual Activity	%	94.0
	12267266	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	71.0	CHEMBL5776	Homo sapiens	Residual Activity	%	71.0
	12267267	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	102.0	CHEMBL5776	Homo sapiens	Residual Activity	%	102.0
	12267268	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	101.0	CHEMBL5776	Homo sapiens	Residual Activity	%	101.0
	12267269	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	53.0	CHEMBL5776	Homo sapiens	Residual Activity	%	53.0
	12267270	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	81.0	CHEMBL5776	Homo sapiens	Residual Activity	%	81.0
	12267271	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	1.0	CHEMBL5776	Homo sapiens	Residual Activity	%	1.0
	12267272	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	83.0	CHEMBL5776	Homo sapiens	Residual Activity	%	83.0
	12267273	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	101.0	CHEMBL5776	Homo sapiens	Residual Activity	%	101.0
	12267274	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	97.0	CHEMBL5776	Homo sapiens	Residual Activity	%	97.0
	12267275	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	96.0	CHEMBL5776	Homo sapiens	Residual Activity	%	96.0
	12267276	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	83.0	CHEMBL5776	Homo sapiens	Residual Activity	%	83.0
	12267277	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	100.0	CHEMBL5776	Homo sapiens	Residual Activity	%	100.0
	12267278	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	89.0	CHEMBL5776	Homo sapiens	Residual Activity	%	89.0
	12267279	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	75.0	CHEMBL5776	Homo sapiens	Residual Activity	%	75.0
	12267280	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	25.0	CHEMBL5776	Homo sapiens	Residual Activity	%	25.0
	12267281	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	89.0	CHEMBL5776	Homo sapiens	Residual Activity	%	89.0
	12267282	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	95.0	CHEMBL5776	Homo sapiens	Residual Activity	%	95.0
	12267283	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	95.0	CHEMBL5776	Homo sapiens	Residual Activity	%	95.0
	12267284	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	81.0	CHEMBL5776	Homo sapiens	Residual Activity	%	81.0
	12267285	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	94.0	CHEMBL5776	Homo sapiens	Residual Activity	%	94.0
	12267286	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	83.0	CHEMBL5776	Homo sapiens	Residual Activity	%	83.0
	12267287	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	93.0	CHEMBL5776	Homo sapiens	Residual Activity	%	93.0
	12267288	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	95.0	CHEMBL5776	Homo sapiens	Residual Activity	%	95.0
	12267289	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	95.0	CHEMBL5776	Homo sapiens	Residual Activity	%	95.0
	12267290	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	99.0	CHEMBL5776	Homo sapiens	Residual Activity	%	99.0
	12267291	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	64.0	CHEMBL5776	Homo sapiens	Residual Activity	%	64.0
	12267292	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	96.0	CHEMBL5776	Homo sapiens	Residual Activity	%	96.0
	12267293	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	74.0	CHEMBL5776	Homo sapiens	Residual Activity	%	74.0
	12267294	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	61.0	CHEMBL5776	Homo sapiens	Residual Activity	%	61.0
	12267295	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	88.0	CHEMBL5776	Homo sapiens	Residual Activity	%	88.0
	12267296	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	-3.0	CHEMBL5776	Homo sapiens	Residual Activity	%	-3.0
	12267297	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	82.0	CHEMBL5776	Homo sapiens	Residual Activity	%	82.0
	12267298	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL5776	Homo sapiens	Residual Activity	%	-1.0
	12267299	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	98.0	CHEMBL5776	Homo sapiens	Residual Activity	%	98.0
	12267300	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	34.0	CHEMBL5776	Homo sapiens	Residual Activity	%	34.0
	12267301	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	84.0	CHEMBL5776	Homo sapiens	Residual Activity	%	84.0
	12267302	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	113.0	CHEMBL5776	Homo sapiens	Residual Activity	%	113.0
	12267303	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	92.0	CHEMBL5776	Homo sapiens	Residual Activity	%	92.0
	12267304	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	92.0	CHEMBL5776	Homo sapiens	Residual Activity	%	92.0
	12267305	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	93.0	CHEMBL5776	Homo sapiens	Residual Activity	%	93.0
	12267306	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	101.0	CHEMBL5776	Homo sapiens	Residual Activity	%	101.0
	12267307	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	89.0	CHEMBL5776	Homo sapiens	Residual Activity	%	89.0
	12267308	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	71.0	CHEMBL5776	Homo sapiens	Residual Activity	%	71.0
	12267309	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	81.0	CHEMBL5776	Homo sapiens	Residual Activity	%	81.0
	12267310	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	77.0	CHEMBL5776	Homo sapiens	Residual Activity	%	77.0
	12267311	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	40.0	CHEMBL5776	Homo sapiens	Residual Activity	%	40.0
	12267312	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	87.0	CHEMBL5776	Homo sapiens	Residual Activity	%	87.0
	12267313	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	90.0	CHEMBL5776	Homo sapiens	Residual Activity	%	90.0
	12267314	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	102.0	CHEMBL5776	Homo sapiens	Residual Activity	%	102.0
	12267315	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	92.0	CHEMBL5776	Homo sapiens	Residual Activity	%	92.0
	12267316	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	88.0	CHEMBL5776	Homo sapiens	Residual Activity	%	88.0
	12267317	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	89.0	CHEMBL5776	Homo sapiens	Residual Activity	%	89.0
	12267318	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	74.0	CHEMBL5776	Homo sapiens	Residual Activity	%	74.0
	12267319	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	30.0	CHEMBL5776	Homo sapiens	Residual Activity	%	30.0
	12267320	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	-5.0	CHEMBL5776	Homo sapiens	Residual Activity	%	-5.0
	12267321	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	98.0	CHEMBL5776	Homo sapiens	Residual Activity	%	98.0
	12267322	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	89.0	CHEMBL5776	Homo sapiens	Residual Activity	%	89.0
	12267323	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	78.0	CHEMBL5776	Homo sapiens	Residual Activity	%	78.0
	12267324	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	92.0	CHEMBL5776	Homo sapiens	Residual Activity	%	92.0
	12267325	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	80.0	CHEMBL5776	Homo sapiens	Residual Activity	%	80.0
	12267326	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	82.0	CHEMBL5776	Homo sapiens	Residual Activity	%	82.0
	12267327	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	81.0	CHEMBL5776	Homo sapiens	Residual Activity	%	81.0
	12267328	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	68.0	CHEMBL5776	Homo sapiens	Residual Activity	%	68.0
	12267329	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	91.0	CHEMBL5776	Homo sapiens	Residual Activity	%	91.0
	12267330	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	97.0	CHEMBL5776	Homo sapiens	Residual Activity	%	97.0
	12267331	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	21.0	CHEMBL5776	Homo sapiens	Residual Activity	%	21.0
	12267332	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	77.0	CHEMBL5776	Homo sapiens	Residual Activity	%	77.0
	12267333	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	81.0	CHEMBL5776	Homo sapiens	Residual Activity	%	81.0
	12267334	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	79.0	CHEMBL5776	Homo sapiens	Residual Activity	%	79.0
	12267335	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	8.0	CHEMBL5776	Homo sapiens	Residual Activity	%	8.0
	12267336	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	82.0	CHEMBL5776	Homo sapiens	Residual Activity	%	82.0
	12267337	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	79.0	CHEMBL5776	Homo sapiens	Residual Activity	%	79.0
	12267338	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	88.0	CHEMBL5776	Homo sapiens	Residual Activity	%	88.0
	12267339	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	89.0	CHEMBL5776	Homo sapiens	Residual Activity	%	89.0
	12267340	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	65.0	CHEMBL5776	Homo sapiens	Residual Activity	%	65.0
	12267341	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	24.0	CHEMBL5776	Homo sapiens	Residual Activity	%	24.0
	12267342	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	82.0	CHEMBL5776	Homo sapiens	Residual Activity	%	82.0
	12267343	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	38.0	CHEMBL5776	Homo sapiens	Residual Activity	%	38.0
	12267344	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	86.0	CHEMBL5776	Homo sapiens	Residual Activity	%	86.0
	12267345	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	20.0	CHEMBL5776	Homo sapiens	Residual Activity	%	20.0
	12267346	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	98.0	CHEMBL5776	Homo sapiens	Residual Activity	%	98.0
	12267347	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	86.0	CHEMBL5776	Homo sapiens	Residual Activity	%	86.0
	12267348	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	2.0	CHEMBL5776	Homo sapiens	Residual Activity	%	2.0
	12267349	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	82.0	CHEMBL5776	Homo sapiens	Residual Activity	%	82.0
	12267350	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	79.0	CHEMBL5776	Homo sapiens	Residual Activity	%	79.0
	12267351	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	19.0	CHEMBL5776	Homo sapiens	Residual Activity	%	19.0
	12267352	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	83.0	CHEMBL5776	Homo sapiens	Residual Activity	%	83.0
	12267353	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	8.0	CHEMBL5776	Homo sapiens	Residual Activity	%	8.0
	12267354	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	30.0	CHEMBL5776	Homo sapiens	Residual Activity	%	30.0
	12267355	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	74.0	CHEMBL5776	Homo sapiens	Residual Activity	%	74.0
	12267356	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	7.0	CHEMBL5776	Homo sapiens	Residual Activity	%	7.0
	12267357	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	81.0	CHEMBL5776	Homo sapiens	Residual Activity	%	81.0
	12268995	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	46.0	CHEMBL5776	Homo sapiens	Residual Activity	%	46.0
	12268996	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	85.0	CHEMBL5776	Homo sapiens	Residual Activity	%	85.0
	12268997	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	88.0	CHEMBL5776	Homo sapiens	Residual Activity	%	88.0
	12268998	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	41.0	CHEMBL5776	Homo sapiens	Residual Activity	%	41.0
	12268999	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	13.0	CHEMBL5776	Homo sapiens	Residual Activity	%	13.0
	12269000	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	102.0	CHEMBL5776	Homo sapiens	Residual Activity	%	102.0
	12269001	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	63.0	CHEMBL5776	Homo sapiens	Residual Activity	%	63.0
	12269002	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	85.0	CHEMBL5776	Homo sapiens	Residual Activity	%	85.0
	12269003	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	81.0	CHEMBL5776	Homo sapiens	Residual Activity	%	81.0
	12269004	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	87.0	CHEMBL5776	Homo sapiens	Residual Activity	%	87.0
	12269005	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	91.0	CHEMBL5776	Homo sapiens	Residual Activity	%	91.0
	12269006	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	21.0	CHEMBL5776	Homo sapiens	Residual Activity	%	21.0
	12269007	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	95.0	CHEMBL5776	Homo sapiens	Residual Activity	%	95.0
	12269008	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	89.0	CHEMBL5776	Homo sapiens	Residual Activity	%	89.0
	12269009	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	81.0	CHEMBL5776	Homo sapiens	Residual Activity	%	81.0
	12269010	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	93.0	CHEMBL5776	Homo sapiens	Residual Activity	%	93.0
	12269011	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	72.0	CHEMBL5776	Homo sapiens	Residual Activity	%	72.0
	12269012	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	101.0	CHEMBL5776	Homo sapiens	Residual Activity	%	101.0
	12269013	CHEMBL2219198	Millipore: Percentage of residual kinase activity of MAP3K7 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	87.0	CHEMBL5776	Homo sapiens	Residual Activity	%	87.0
	12668338	CHEMBL2345074	Inhibition of MAP3K7 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(N3CCOCC3)ccc12		CHEMBL2333120	=	Inhibition	%	67.0	CHEMBL5776	Homo sapiens	INH	%	67.0
	12668339	CHEMBL2345074	Inhibition of MAP3K7 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3cn[nH]c3)cc12		CHEMBL2333115	=	Inhibition	%	97.0	CHEMBL5776	Homo sapiens	INH	%	97.0
	12668340	CHEMBL2345074	Inhibition of MAP3K7 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3ccncc3)cc12		CHEMBL2333114	=	Inhibition	%	84.0	CHEMBL5776	Homo sapiens	INH	%	84.0
	12668341	CHEMBL2345074	Inhibition of MAP3K7 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(-c3ccncc3)ccc12		CHEMBL2333112	=	Inhibition	%	102.0	CHEMBL5776	Homo sapiens	INH	%	102.0
	12668342	CHEMBL2345074	Inhibition of MAP3K7 (unknown origin) at 10 uM relative to control	B	CS(=O)(=O)c1ccc(-c2ccc3c(NC4CCC4)c(C(N)=O)nnc3c2)cc1		CHEMBL2333129	=	Inhibition	%	66.0	CHEMBL5776	Homo sapiens	INH	%	66.0
	12668343	CHEMBL2345074	Inhibition of MAP3K7 (unknown origin) at 10 uM relative to control	B	C[C@@H](Nc1c(C(N)=O)nnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12)C1CC1		CHEMBL2333128	=	Inhibition	%	39.0	CHEMBL5776	Homo sapiens	INH	%	39.0
	12668344	CHEMBL2345074	Inhibition of MAP3K7 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2333125	=	Inhibition	%	89.0	CHEMBL5776	Homo sapiens	INH	%	89.0
	12672885	CHEMBL2341144	Inhibition of recombinant TAK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	13.0	CHEMBL5776	Homo sapiens	Activity	%	13.0
	12672886	CHEMBL2341144	Inhibition of recombinant TAK1 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	7.0	CHEMBL5776	Homo sapiens	Activity	%	7.0
	12723656	CHEMBL2350754	Inhibition of MAP3K7 (unknown origin) at 10 uM by single point assay	B	C[C@@H](Nc1c(C#N)cnc2cc(-c3ccc(-n4ccoc4=O)cc3)ccc12)C1CC1		CHEMBL2347818	=	Inhibition	%	-5.0	CHEMBL5776	Homo sapiens	INH	%	-5.0
	12724754	CHEMBL2352274	Inhibition of MAP3K7 (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3cnn(C)c3)ccc12		CHEMBL2347824	=	Inhibition	%	51.0	CHEMBL5776	Homo sapiens	INH	%	51.0
	12724755	CHEMBL2352274	Inhibition of MAP3K7 (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2347823	=	Inhibition	%	7.0	CHEMBL5776	Homo sapiens	INH	%	7.0
Not Determined	13390588	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cnc6cnccn56)cc34)cn2)CC1		CHEMBL2407764		IC50			CHEMBL5776	Homo sapiens	IC50		
Not Determined	13390589	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5ccc(C(=O)N(C)C)cc5)cc34)cn2)CC1		CHEMBL2407754		IC50			CHEMBL5776	Homo sapiens	IC50		
Not Determined	13390590	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5ccc(NS(C)(=O)=O)cc5)cc34)cn2)CC1		CHEMBL2407776		IC50			CHEMBL5776	Homo sapiens	IC50		
Not Determined	13390591	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc(S(N)(=O)=O)c5)cc34)cn2)CC1		CHEMBL2407790		IC50			CHEMBL5776	Homo sapiens	IC50		
Not Determined	13390592	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5ccccc5C(F)(F)F)cc34)cn2)CC1		CHEMBL2407782		IC50			CHEMBL5776	Homo sapiens	IC50		
Not Determined	13390593	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)Nc1ccccc1-c1cc2c(-c3cnn(C4CCN(C(C)=O)CC4)c3)cnc(N)c2o1		CHEMBL2407780		IC50			CHEMBL5776	Homo sapiens	IC50		
	13390597	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5ccc(S(C)(=O)=O)cc5)cc34)cn2)CC1		CHEMBL2407774	>	IC50	nM	20000.0	CHEMBL5776	Homo sapiens	IC50	uM	20.0
	13390604	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cn[nH]c5)cc34)cn2)CC1		CHEMBL2407966	=	IC50	nM	9100.0	CHEMBL5776	Homo sapiens	IC50	uM	9.1
	13390605	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)Nc1cccc(-c2cc3c(-c4cnn(C5CCN(C(C)=O)CC5)c4)cnc(N)c3o2)c1		CHEMBL2407794	=	IC50	nM	9000.0	CHEMBL5776	Homo sapiens	IC50	uM	9.0
	13390606	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5ccc(OC(F)(F)F)cc5)cc34)cn2)CC1		CHEMBL2407752	=	IC50	nM	8000.0	CHEMBL5776	Homo sapiens	IC50	uM	8.0
	13390609	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CSc1ccc(-c2cc3c(-c4cnn(C5CCN(C(C)=O)CC5)c4)cnc(N)c3o2)cc1		CHEMBL2407773	=	IC50	nM	5200.0	CHEMBL5776	Homo sapiens	IC50	uM	5.2
	13390612	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5ccccc5C(N)=O)cc34)cn2)CC1		CHEMBL2407784	=	IC50	nM	4500.0	CHEMBL5776	Homo sapiens	IC50	uM	4.5
	13390613	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5ccc(CO)cc5)cc34)cn2)CC1		CHEMBL2407755	=	IC50	nM	4400.0	CHEMBL5776	Homo sapiens	IC50	uM	4.4
	13390615	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc(CN)c5)cc34)cn2)CC1		CHEMBL2407771	=	IC50	nM	4000.0	CHEMBL5776	Homo sapiens	IC50	uM	4.0
	13390620	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc(C(N)=O)c5)cc34)cn2)CC1		CHEMBL2407770	=	IC50	nM	3100.0	CHEMBL5776	Homo sapiens	IC50	uM	3.1
	13390621	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)c1ccccc1-c1cc2c(-c3cnn(C4CCN(C(C)=O)CC4)c3)cnc(N)c2o1		CHEMBL2407783	=	IC50	nM	3100.0	CHEMBL5776	Homo sapiens	IC50	uM	3.1
	13390622	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5ccc(C#N)cc5)cc34)cn2)CC1		CHEMBL2407753	=	IC50	nM	2800.0	CHEMBL5776	Homo sapiens	IC50	uM	2.8
	13390626	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	COCCOc1cccc(-c2cc3c(-c4cnn(C5CCN(C(C)=O)CC5)c4)cnc(N)c3o2)c1		CHEMBL2407956	=	IC50	nM	2700.0	CHEMBL5776	Homo sapiens	IC50	uM	2.7
	13390631	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5ccc(CC#N)cc5)cc34)cn2)CC1		CHEMBL2407756	=	IC50	nM	1900.0	CHEMBL5776	Homo sapiens	IC50	uM	1.9
	13390632	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc(OC(F)(F)F)c5)cc34)cn2)CC1		CHEMBL2407957	=	IC50	nM	1800.0	CHEMBL5776	Homo sapiens	IC50	uM	1.8
	13390633	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	COCc1ccccc1-c1cc2c(-c3cnn(C4CCN(C(C)=O)CC4)c3)cnc(N)c2o1		CHEMBL2407786	=	IC50	nM	1800.0	CHEMBL5776	Homo sapiens	IC50	uM	1.8
	13390637	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5ccccc5C#N)cc34)cn2)CC1		CHEMBL2407781	=	IC50	nM	1700.0	CHEMBL5776	Homo sapiens	IC50	uM	1.7
	13390639	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc(C(F)(F)F)c5)cc34)cn2)CC1		CHEMBL2407768	=	IC50	nM	1600.0	CHEMBL5776	Homo sapiens	IC50	uM	1.6
	13390641	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5ccccc5CO)cc34)cn2)CC1		CHEMBL2407785	=	IC50	nM	1500.0	CHEMBL5776	Homo sapiens	IC50	uM	1.5
	13390646	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc6ccccc56)cc34)cn2)CC1		CHEMBL2407762	=	IC50	nM	1200.0	CHEMBL5776	Homo sapiens	IC50	uM	1.2
	13390647	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	COc1cccc(-c2cc3c(-c4cnn(C5CCN(C(C)=O)CC5)c4)cnc(N)c3o2)c1		CHEMBL2407796	=	IC50	nM	1200.0	CHEMBL5776	Homo sapiens	IC50	uM	1.2
	13390648	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CSc1cccc(-c2cc3c(-c4cnn(C5CCN(C(C)=O)CC5)c4)cnc(N)c3o2)c1		CHEMBL2407788	=	IC50	nM	1200.0	CHEMBL5776	Homo sapiens	IC50	uM	1.2
	13390651	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc(S(=O)(=O)N(C)C)c5)cc34)cn2)CC1		CHEMBL2407791	=	IC50	nM	1100.0	CHEMBL5776	Homo sapiens	IC50	uM	1.1
	13390652	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc(S(C)(=O)=O)c5)cc34)cn2)CC1		CHEMBL2407789	=	IC50	nM	1100.0	CHEMBL5776	Homo sapiens	IC50	uM	1.1
	13390656	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5ccc(N)cc5)cc34)cn2)CC1		CHEMBL2407775	=	IC50	nM	1000.0	CHEMBL5776	Homo sapiens	IC50	uM	1.0
	13390657	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)c1cccc(-c2cc3c(-c4cnn(C5CCN(C(C)=O)CC5)c4)cnc(N)c3o2)c1		CHEMBL2407769	=	IC50	nM	1000.0	CHEMBL5776	Homo sapiens	IC50	uM	1.0
	13390673	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc(N(C)C)c5)cc34)cn2)CC1		CHEMBL2407098	=	IC50	nM	690.0	CHEMBL5776	Homo sapiens	IC50	uM	0.69
	13390682	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc(O)c5)cc34)cn2)CC1		CHEMBL2407795	=	IC50	nM	610.0	CHEMBL5776	Homo sapiens	IC50	uM	0.61
	13390684	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5ccccc5CC#N)cc34)cn2)CC1		CHEMBL2407787	=	IC50	nM	530.0	CHEMBL5776	Homo sapiens	IC50	uM	0.53
	13390687	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5ccccc5)cc34)cn2)CC1		CHEMBL2407958	=	IC50	nM	520.0	CHEMBL5776	Homo sapiens	IC50	uM	0.52
	13390688	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc(N)c5)cc34)cn2)CC1		CHEMBL2407793	=	IC50	nM	510.0	CHEMBL5776	Homo sapiens	IC50	uM	0.51
	13390690	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5ccc(O)cc5)cc34)cn2)CC1		CHEMBL2407777	=	IC50	nM	500.0	CHEMBL5776	Homo sapiens	IC50	uM	0.5
	13390691	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CSc1ccccc1-c1cc2c(-c3cnn(C4CCN(C(C)=O)CC4)c3)cnc(N)c2o1		CHEMBL2407779	=	IC50	nM	500.0	CHEMBL5776	Homo sapiens	IC50	uM	0.5
	13390693	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc(CO)c5)cc34)cn2)CC1		CHEMBL2407772	=	IC50	nM	470.0	CHEMBL5776	Homo sapiens	IC50	uM	0.47
	13390695	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5csc6ccccc56)cc34)cn2)CC1		CHEMBL2407763	=	IC50	nM	440.0	CHEMBL5776	Homo sapiens	IC50	uM	0.44
	13390697	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc(C#N)c5)cc34)cn2)CC1		CHEMBL2407767	=	IC50	nM	370.0	CHEMBL5776	Homo sapiens	IC50	uM	0.37
	13390698	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cn(C)c6cnccc56)cc34)cn2)CC1		CHEMBL2407761	=	IC50	nM	340.0	CHEMBL5776	Homo sapiens	IC50	uM	0.34
	13390703	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc([N+](=O)[O-])c5)cc34)cn2)CC1		CHEMBL2407792	=	IC50	nM	200.0	CHEMBL5776	Homo sapiens	IC50	uM	0.2
	13390705	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5csc6cnccc56)cc34)cn2)CC1		CHEMBL2407760	=	IC50	nM	110.0	CHEMBL5776	Homo sapiens	IC50	uM	0.11
	13390708	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc6cnsc56)cc34)cn2)CC1		CHEMBL2407757	=	IC50	nM	44.0	CHEMBL5776	Homo sapiens	IC50	uM	0.044
	13390713	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc6nnsc56)cc34)cn2)CC1		CHEMBL2407759	=	IC50	nM	12.0	CHEMBL5776	Homo sapiens	IC50	uM	0.012
	13390714	CHEMBL2412855	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	CC(=O)N1CCC(n2cc(-c3cnc(N)c4oc(-c5cccc6ncsc56)cc34)cn2)CC1		CHEMBL2407758	=	IC50	nM	10.0	CHEMBL5776	Homo sapiens	IC50	uM	0.01
	13396481	CHEMBL2410822	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	Cn1cc(-c2cnc(N)c3oc(-c4csc5cnccc45)cc23)c(C#N)n1		CHEMBL2408735	>	IC50	nM	10000.0	CHEMBL5776	Homo sapiens	IC50	uM	10.0
	13396533	CHEMBL2410822	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	Cc1nn(C)c(C)c1-c1cnc(N)c2oc(-c3csc4cnccc34)cc12		CHEMBL2408733	=	IC50	nM	4400.0	CHEMBL5776	Homo sapiens	IC50	uM	4.4
	13396543	CHEMBL2410822	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	Cc1c(-c2cnc(N)c3oc(-c4csc5cnccc45)cc23)cnn1C		CHEMBL2408732	=	IC50	nM	3000.0	CHEMBL5776	Homo sapiens	IC50	uM	3.0
	13396554	CHEMBL2410822	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	COc1nn(C)cc1-c1cnc(N)c2oc(-c3csc4cnccc34)cc12		CHEMBL2408734	=	IC50	nM	1700.0	CHEMBL5776	Homo sapiens	IC50	uM	1.7
	13396562	CHEMBL2410822	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	Cc1nn(C)cc1-c1cnc(N)c2oc(-c3csc4cnccc34)cc12		CHEMBL2408731	=	IC50	nM	1000.0	CHEMBL5776	Homo sapiens	IC50	uM	1.0
	13396583	CHEMBL2410822	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	Cn1cc(-c2cnc(N)c3oc(-c4csc5cnccc45)cc23)cn1		CHEMBL2408617	=	IC50	nM	190.0	CHEMBL5776	Homo sapiens	IC50	uM	0.19
	13396587	CHEMBL2410822	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	Nc1ncc(-c2cnn([C@H]3CC[C@H](O)CC3)c2)c2c(-c3cccnc3)c(-c3cccc4nnsc34)oc12		CHEMBL2408613	=	IC50	nM	130.0	CHEMBL5776	Homo sapiens	IC50	uM	0.13
	13396590	CHEMBL2410822	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	Nc1ncc(-c2cnn([C@H]3CC[C@H](O)CC3)c2)c2c(CF)c(-c3cccc4nnsc34)oc12		CHEMBL2408615	=	IC50	nM	45.0	CHEMBL5776	Homo sapiens	IC50	uM	0.045
	13396591	CHEMBL2410822	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	Nc1ncc(-c2cnn([C@H]3CC[C@H](O)CC3)c2)c2c(-c3cncs3)c(-c3cccc4nnsc34)oc12		CHEMBL2408614	=	IC50	nM	43.0	CHEMBL5776	Homo sapiens	IC50	uM	0.043
	13396594	CHEMBL2410644	Inhibition of TAK1 in human TOV21G cells assessed as inhibition of JNK phosphorylation	B	Nc1ncc(-c2cnn([C@H]3CC[C@H](O)CC3)c2)c2c(Cl)c(-c3cccc4nnsc34)oc12		CHEMBL2408611	=	IC50	nM	28.0	CHEMBL5776	Homo sapiens	IC50	uM	0.028
	13396596	CHEMBL2410822	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	Nc1ncc(-c2cnn([C@H]3CC[C@H](O)CC3)c2)c2c(C(F)F)c(-c3cccc4nnsc34)oc12		CHEMBL2408616	=	IC50	nM	20.0	CHEMBL5776	Homo sapiens	IC50	uM	0.02
	13396597	CHEMBL2410822	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	Nc1ncc(-c2cnn([C@H]3CC[C@H](O)CC3)c2)c2c(Cl)c(-c3cccc4nnsc34)oc12		CHEMBL2408611	=	IC50	nM	18.0	CHEMBL5776	Homo sapiens	IC50	uM	0.018
	13396598	CHEMBL2410822	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	N#Cc1c(-c2cccc3nnsc23)oc2c(N)ncc(-c3cnn([C@H]4CC[C@H](O)CC4)c3)c12		CHEMBL2408612	=	IC50	nM	17.0	CHEMBL5776	Homo sapiens	IC50	uM	0.017
	13396600	CHEMBL2410822	Inhibition of TAK1 in human HCT116 cells assessed as inhibition of TNF-alpha-stimulated JNK phosphorylation	B	Nc1ncc(-c2cnn([C@H]3CC[C@H](O)CC3)c2)c2cc(-c3cccc4nnsc34)oc12		CHEMBL2408610	=	IC50	nM	15.0	CHEMBL5776	Homo sapiens	IC50	uM	0.015
Not Active	13508511	CHEMBL2447620	Inhibition of TAK1 (unknown origin) at 30 uM	B	O=C(Nc1ccc2c(c1)B(O)OC2)c1c(C(F)(F)F)ccc(Cl)c1F		CHEMBL2441375		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
	13871736	CHEMBL3100772	Inhibition of human TAK1 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	95.0	CHEMBL5776	Homo sapiens	Activity	%	95.0
	13953369	CHEMBL3130937	Inhibition of human TAK1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	85.0	CHEMBL5776	Homo sapiens	Activity	%	85.0
	13954716	CHEMBL3130937	Inhibition of human TAK1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	85.0	CHEMBL5776	Homo sapiens	Activity	%	85.0
	13954730	CHEMBL3130937	Inhibition of human TAK1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	79.0	CHEMBL5776	Homo sapiens	Activity	%	79.0
	14664332	CHEMBL3271270	Inhibition of TAK1 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	65.0	CHEMBL5776	Homo sapiens	INH	%	65.0
	14664333	CHEMBL3271270	Inhibition of TAK1 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	34.0	CHEMBL5776	Homo sapiens	INH	%	34.0
	14664334	CHEMBL3271270	Inhibition of TAK1 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	49.0	CHEMBL5776	Homo sapiens	INH	%	49.0
	14668879	CHEMBL3269302	Inhibition of TAK1 (unknown origin) assessed as residual activity at 1 uM	B	CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1		CHEMBL3264257	=	Activity	%	106.0	CHEMBL5776	Homo sapiens	Activity	%	106.0
	14991960	CHEMBL3374134	Inhibition of TAK1 (unknown origin) using unphosphorylated GST-tagged MAP2K7 substrate protein assessed as phosphorylation by ELISA	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	IC50	nM	80.0	CHEMBL5776	Homo sapiens	IC50	uM	0.08
Not Active	14999361	CHEMBL3368452	Inhibition of human TAK1 at 10 uM relative to control	B	CC(C)(C)C1=NN(c2ccc(Cl)cc2)C(c2ccc(O)cc2)C1		CHEMBL3323314		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
	15112146	CHEMBL3388158	Inhibition of TAK1 (unknown origin)	B	COc1ccc(-c2cccc3nc(NC(=O)C4CC4)nn23)cc1		CHEMBL3360318	>	IC50	nM	10000.0	CHEMBL5776	Homo sapiens	IC50	nM	10000.0
	15144930	CHEMBL3396439	Competitive binding affinity at TAK1 (unknown origin) at 1 uM relative to control	B	Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1		CHEMBL3393706	=	Activity	%	32.0	CHEMBL5776	Homo sapiens	Activity	%	32.0
	15251856	CHEMBL3428225	Inhibition of TAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	59.0	CHEMBL5776	Homo sapiens	Activity	%	59.0
	15251941	CHEMBL3428225	Inhibition of TAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	8.0	CHEMBL5776	Homo sapiens	Activity	%	8.0
	15252043	CHEMBL3428225	Inhibition of TAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	81.0	CHEMBL5776	Homo sapiens	Activity	%	81.0
	15252688	CHEMBL3428225	Inhibition of TAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	98.0	CHEMBL5776	Homo sapiens	Activity	%	98.0
	15252790	CHEMBL3428225	Inhibition of TAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	89.0	CHEMBL5776	Homo sapiens	Activity	%	89.0
	15252892	CHEMBL3428225	Inhibition of TAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	99.0	CHEMBL5776	Homo sapiens	Activity	%	99.0
	15253566	CHEMBL3428225	Inhibition of TAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	60.0	CHEMBL5776	Homo sapiens	Activity	%	60.0
	15253668	CHEMBL3428225	Inhibition of TAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	75.0	CHEMBL5776	Homo sapiens	Activity	%	75.0
	15253770	CHEMBL3428225	Inhibition of TAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	89.0	CHEMBL5776	Homo sapiens	Activity	%	89.0
	15254436	CHEMBL3428225	Inhibition of TAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	58.0	CHEMBL5776	Homo sapiens	Activity	%	58.0
	15254538	CHEMBL3428225	Inhibition of TAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	70.0	CHEMBL5776	Homo sapiens	Activity	%	70.0
	15254640	CHEMBL3428225	Inhibition of TAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	50.0	CHEMBL5776	Homo sapiens	Activity	%	50.0
	15255331	CHEMBL3428225	Inhibition of TAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	83.0	CHEMBL5776	Homo sapiens	Activity	%	83.0
	15255433	CHEMBL3428225	Inhibition of TAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	81.0	CHEMBL5776	Homo sapiens	Activity	%	81.0
	15255536	CHEMBL3428225	Inhibition of TAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	79.0	CHEMBL5776	Homo sapiens	Activity	%	79.0
	15256267	CHEMBL3428225	Inhibition of TAK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	69.0	CHEMBL5776	Homo sapiens	Activity	%	69.0
	15686159	CHEMBL3606885	Inhibition of TAK1 (unknown origin) at 2 uM by radioactive filter-binding assay	B	NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I		CHEMBL3605056	>=	Inhibition	%	80.0	CHEMBL5776	Homo sapiens	INH	%	80.0
	15686193	CHEMBL3606984	Inhibition of TAK1 (unknown origin) at 250 nM by radioactive filter-binding assay	B	c1ccc2c(Nc3cc(C4CCC4)[nH]n3)nc(Nc3ccc4[nH]cnc4c3)nc2c1		CHEMBL3605055	>=	Inhibition	%	80.0	CHEMBL5776	Homo sapiens	INH	%	80.0
	15750301	CHEMBL3632095	Inhibition of TAK1 (unknown origin)	B	COC1=CC(O)C2C(=O)O[C@@H](C)CC3CC(=O)[C@@H](O)[C@H](C/C=C/C2=C1)O3		CHEMBL3628303	>	IC50	nM	30000.0	CHEMBL5776	Homo sapiens	IC50	uM	30.0
	15750302	CHEMBL3632095	Inhibition of TAK1 (unknown origin)	B	C/C=C/C=C\C(=O)[C@@H](O)[C@@H](O)C/C=C/c1cc(OC)cc(OC)c1C(=O)OC		CHEMBL3629248	>	IC50	nM	30000.0	CHEMBL5776	Homo sapiens	IC50	uM	30.0
	15750303	CHEMBL3632095	Inhibition of TAK1 (unknown origin)	B	COc1cc(O)cc2c1C(=O)O[C@@H](C)CCCCC/C=C/C(=O)C2		CHEMBL3334712	>	IC50	nM	30000.0	CHEMBL5776	Homo sapiens	IC50	uM	30.0
	15750304	CHEMBL3632095	Inhibition of TAK1 (unknown origin)	B	COc1cc(O)c2c(c1)[C@H]1O[C@@H]1C[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL3629247	>	IC50	nM	30000.0	CHEMBL5776	Homo sapiens	IC50	uM	30.0
	15750305	CHEMBL3632095	Inhibition of TAK1 (unknown origin)	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)[C@@H](O)/C=C/C[C@H](C)OC2=O		CHEMBL1099228	=	IC50	nM	10000.0	CHEMBL5776	Homo sapiens	IC50	uM	10.0
	15750306	CHEMBL3632095	Inhibition of TAK1 (unknown origin)	B	COc1c(Br)c(O)c2c(c1Br)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL3629246	=	IC50	nM	8900.0	CHEMBL5776	Homo sapiens	IC50	uM	8.9
	15750307	CHEMBL3632095	Inhibition of TAK1 (unknown origin)	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)CCC[C@H](C)OC2=O		CHEMBL1801951	=	IC50	nM	2600.0	CHEMBL5776	Homo sapiens	IC50	uM	2.6
	15750308	CHEMBL3632095	Inhibition of TAK1 (unknown origin)	B	COc1cc2c(c(O)c1Br)C(=O)O[C@@H](C)C/C=C\C(=O)[C@@H](O)[C@@H](O)C/C=C/2		CHEMBL3629245	=	IC50	nM	2600.0	CHEMBL5776	Homo sapiens	IC50	uM	2.6
	15750309	CHEMBL3632095	Inhibition of TAK1 (unknown origin)	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1801950	=	IC50	nM	1300.0	CHEMBL5776	Homo sapiens	IC50	uM	1.3
	15750310	CHEMBL3632095	Inhibition of TAK1 (unknown origin)	B	COc1cc(O)c2c(c1)[C@H]1O[C@@H]1C[C@H](O)[C@H](O)C(=O)/C=C/C[C@H](C)OC2=O		CHEMBL3629244	=	IC50	nM	990.0	CHEMBL5776	Homo sapiens	IC50	uM	0.99
	15750311	CHEMBL3632095	Inhibition of TAK1 (unknown origin)	B	COc1cc(O)c2c(c1)/C=C/C[C@@H]1OC(C)(C)O[C@@H]1C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL3629243	=	IC50	nM	380.0	CHEMBL5776	Homo sapiens	IC50	uM	0.38
	15750312	CHEMBL3632095	Inhibition of TAK1 (unknown origin)	B	COc1cc(O)c2c(c1Br)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL3629242	=	IC50	nM	360.0	CHEMBL5776	Homo sapiens	IC50	uM	0.36
	15750313	CHEMBL3632095	Inhibition of TAK1 (unknown origin)	B	COC1=CC(O)C2=C(/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O)C1(F)F		CHEMBL3629241	=	IC50	nM	77.0	CHEMBL5776	Homo sapiens	IC50	uM	0.077
	15750314	CHEMBL3632095	Inhibition of TAK1 (unknown origin)	B	COc1cc(O)c2c(c1)[C@H]1O[C@@H]1C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL471474	=	IC50	nM	33.0	CHEMBL5776	Homo sapiens	IC50	uM	0.033
	15750315	CHEMBL3632095	Inhibition of TAK1 (unknown origin)	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	IC50	nM	11.0	CHEMBL5776	Homo sapiens	IC50	uM	0.011
	15750316	CHEMBL3632094	Inhibition of TAK1 (unknown origin) expressed in sf9 cells assessed as 32P level incorporation into myelin basic protein incubated for 5 mins at 30 degC by immunoprecipitation method	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	IC50	nM	8.1	CHEMBL5776	Homo sapiens	IC50	nM	8.1
	15756797	CHEMBL3631489	Inhibition of TAK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	83.75	CHEMBL5776	Homo sapiens	INH	%	83.75
	15757926	CHEMBL3631489	Inhibition of TAK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	83.05	CHEMBL5776	Homo sapiens	INH	%	83.05
	15758905	CHEMBL3631489	Inhibition of TAK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	6.56	CHEMBL5776	Homo sapiens	INH	%	6.56
	16391786	CHEMBL3737184	Inhibition of TAK1 (unknown origin)	B	O=C(Nc1nc2cc(CN3CCCCC3)ccc2n1[C@H]1CC[C@H](O)CC1)c1cccc([N+](=O)[O-])c1		CHEMBL3735673	=	Ki	nM	15.0	CHEMBL5776	Homo sapiens	Ki	nM	15.0
	16391787	CHEMBL3737184	Inhibition of TAK1 (unknown origin)	B	O=C(Nc1nc2cc(CN3CCCCC3)ccc2n1[C@H]1CC[C@@H](CO)CC1)c1cccc([N+](=O)[O-])c1		CHEMBL3734854	=	Ki	nM	30.0	CHEMBL5776	Homo sapiens	Ki	nM	30.0
	16391788	CHEMBL3737184	Inhibition of TAK1 (unknown origin)	B	O=C(Nc1nc2cc(CN3CCCCC3)ccc2n1[C@H]1CC[C@@H](CO)CC1)c1cccc(C(F)(F)F)c1		CHEMBL3736036	=	Ki	nM	130.0	CHEMBL5776	Homo sapiens	Ki	nM	130.0
	16391789	CHEMBL3737184	Inhibition of TAK1 (unknown origin)	B	O=C(Nc1nc2cc(CN3CCCCC3)ccc2n1-c1ccccc1)c1cccc([N+](=O)[O-])c1		CHEMBL3735719	=	Ki	nM	800.0	CHEMBL5776	Homo sapiens	Ki	nM	800.0
	16391790	CHEMBL3737184	Inhibition of TAK1 (unknown origin)	B	O=C(Nc1nc2cc(CN3CCCCC3)ccc2n1-c1ccccc1)c1cccc(C(F)(F)F)c1		CHEMBL3736278	=	Ki	nM	2500.0	CHEMBL5776	Homo sapiens	Ki	nM	2500.0
	16391791	CHEMBL3737184	Inhibition of TAK1 (unknown origin)	B	O=C(Nc1nc2cc(CN3CCCCC3)ccc2n1-c1ccc(CCO)cc1)c1cccc(C(F)(F)F)c1		CHEMBL3736465	=	Ki	nM	700.0	CHEMBL5776	Homo sapiens	Ki	nM	700.0
	16391792	CHEMBL3737184	Inhibition of TAK1 (unknown origin)	B	CC(C)(C)C(=O)Nc1ccc2c(c1)nc(NC(=O)c1cccc(C(F)(F)F)c1)n2[C@H]1CC[C@@H](CO)CC1		CHEMBL3735504	=	Ki	nM	2500.0	CHEMBL5776	Homo sapiens	Ki	nM	2500.0
	16391793	CHEMBL3737184	Inhibition of TAK1 (unknown origin)	B	O=C(Nc1nc2ccc(CO)cc2n1[C@H]1CC[C@@H](CO)CC1)c1cccc(C(F)(F)F)c1		CHEMBL3734814	=	Ki	nM	1300.0	CHEMBL5776	Homo sapiens	Ki	nM	1300.0
	16432021	CHEMBL3750175	Inhibition of human TAK1 using casein as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5776	Homo sapiens	IC50	uM	10.0
	16495236	CHEMBL3778879	Inhibition of N-terminal His6-tagged recombinant human TAK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-15.0	CHEMBL5776	Homo sapiens	Activity	%	-15.0
	16496155	CHEMBL3778879	Inhibition of N-terminal His6-tagged recombinant human TAK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-2.0	CHEMBL5776	Homo sapiens	Activity	%	-2.0
	16501360	CHEMBL3778049	Inhibition of human MAP3K7 by flashplate based radiometric 33pan-quinase assay	B	CS(=O)(=O)O.Cc1oc2c(O)c3c(c(O)c2c1C(=O)N1CC[C@H](N)C1)C(=O)c1ccccc1C3=O		CHEMBL3775181	<	IC50	nM	5000.0	CHEMBL5776	Homo sapiens	IC50	uM	5.0
	16507171	CHEMBL3779006	Inhibition of recombinant TAK1 (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632	>=	Activity	%	100.0	CHEMBL5776	Homo sapiens	Activity	%	100.0
	16508945	CHEMBL3778879	Inhibition of N-terminal His6-tagged recombinant human TAK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	5.0	CHEMBL5776	Homo sapiens	Activity	%	5.0
	16578344	CHEMBL3804398	Inhibition of partial length wild type human TAK1 expressed in mammalian system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	70.0	CHEMBL5776	Homo sapiens	Activity	%	70.0
	16612742	CHEMBL3815740	Inhibition of human TAB1 fused TAK1 (1 to 303 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-82.0	CHEMBL5776	Homo sapiens	Activity	%	-82.0
	16614641	CHEMBL3816857	Inhibition of human TAK1 at 1 uM using casein as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	6.0	CHEMBL5776	Homo sapiens	INH	%	6.0
	16643227	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	Cc1cc(C(=O)N2CCN(C)CC2)ccc1NC(=O)c1csc2c(=O)[nH]cnc12		CHEMBL3823018	=	IC50	nM	41.0	CHEMBL5776	Homo sapiens	IC50	nM	41.0
	16643228	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	CC(C)c1cc(C(=O)N2CCN(C)CC2)ccc1NC(=O)c1csc2c(=O)[nH]cnc12		CHEMBL3823882	=	IC50	nM	3.5	CHEMBL5776	Homo sapiens	IC50	nM	3.5
	16643229	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	CN1CCN(C(=O)c2ccc(NC(=O)c3csc4c(=O)[nH]cnc34)c(-c3ccccc3)c2)CC1		CHEMBL3823127	=	IC50	nM	2.3	CHEMBL5776	Homo sapiens	IC50	nM	2.3
	16643230	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	CN1CCN(C(=O)c2ccc(NC(=O)c3csc4c(=O)[nH]cnc34)c(C3CCCCC3)c2)CC1		CHEMBL3822889	=	IC50	nM	6.7	CHEMBL5776	Homo sapiens	IC50	nM	6.7
	16643231	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	CN1CCN(C(=O)c2ccc(NC(=O)c3csc4c(=O)[nH]cnc34)c(F)c2)CC1		CHEMBL3823067	=	IC50	nM	220.0	CHEMBL5776	Homo sapiens	IC50	nM	220.0
	16643232	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	CN1CCN(C(=O)c2ccc(NC(=O)c3csc4c(=O)[nH]cnc34)c(Cl)c2)CC1		CHEMBL3823000	=	IC50	nM	5.8	CHEMBL5776	Homo sapiens	IC50	nM	5.8
	16643233	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	CN1CCN(C(=O)c2ccc(NC(=O)c3csc4c(=O)[nH]cnc34)c(Br)c2)CC1		CHEMBL3823892	=	IC50	nM	7.3	CHEMBL5776	Homo sapiens	IC50	nM	7.3
	16643234	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	COc1cc(C(=O)N2CCN(C)CC2)ccc1NC(=O)c1csc2c(=O)[nH]cnc12		CHEMBL3824212	=	IC50	nM	15.0	CHEMBL5776	Homo sapiens	IC50	nM	15.0
	16643235	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	CC(F)Oc1cc(C(=O)N2CCN(C)CC2)ccc1NC(=O)c1csc2c(=O)[nH]cnc12		CHEMBL3823992	=	IC50	nM	3.0	CHEMBL5776	Homo sapiens	IC50	nM	3.0
	16643236	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	CN1CCN(C(=O)c2ccc(NC(=O)c3csc4c(=O)[nH]cnc34)c(OC(C(F)(F)F)C(F)(F)F)c2)CC1		CHEMBL3822712	=	IC50	nM	5.2	CHEMBL5776	Homo sapiens	IC50	nM	5.2
	16643237	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	CN1CCN(C(=O)c2ccc(NC(=O)c3csc4c(=O)[nH]cnc34)c(N(C)C)c2)CC1		CHEMBL3822845	=	IC50	nM	5.0	CHEMBL5776	Homo sapiens	IC50	nM	5.0
	16643238	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	CCN(C)c1cc(C(=O)N2CCN(C)CC2)ccc1NC(=O)c1csc2c(=O)[nH]cnc12		CHEMBL3822535	=	IC50	nM	9.3	CHEMBL5776	Homo sapiens	IC50	nM	9.3
	16643239	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	COc1cc(C(=O)NCCCN2CCN(C)CC2)ccc1NC(=O)c1csc2c(=O)[nH]cnc12		CHEMBL3823335	=	IC50	nM	13.0	CHEMBL5776	Homo sapiens	IC50	nM	13.0
	16643240	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	CC(C)Oc1c(NC(=O)c2csc3c(=O)[nH]cnc23)cccc1C(=O)N1CCN(C)CC1		CHEMBL3823738	=	IC50	nM	11.0	CHEMBL5776	Homo sapiens	IC50	nM	11.0
	16643265	CHEMBL3826554	Inhibition of full length TAK1 (unknown origin) fused with TAB1 using biotin-MKK6 as substrate by AlphaScreen assay	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	IC50	nM	9.0	CHEMBL5776	Homo sapiens	IC50	nM	9.0
	16643266	CHEMBL3826555	Inhibition of human recombinant TAK1 fused with TAB1 using MKK6 as substrate in presence of gamma-[33P]ATP	B	C[C@H]1OC=C2[C@H](O)[C@H]3O[C@H]3C(=O)[C@]23[C@H]2O[C@H](C)[C@@H](C4=C2[C@H](O)[C@H]2O[C@H]2C4=O)[C@H]13		CHEMBL3823800	=	IC50	nM	20000.0	CHEMBL5776	Homo sapiens	IC50	uM	20.0
	16643267	CHEMBL3826556	Inhibition of TAK1 (unknown origin)	B	COCCN1CCN(Cc2ccc(-c3cc(NC(N)=O)c(C(N)=O)s3)cc2)CC1		CHEMBL3824153	=	IC50	nM	50.0	CHEMBL5776	Homo sapiens	IC50	nM	50.0
	16643268	CHEMBL3826557	Inhibition of recombinant FLAG-tagged TAK1 kinase domain (unknown origin) expressed in baculovirus expression system coexpressing TAB using biotin-labeled MKK6kd substrate incubated for 1 hr by AlphaScreen assay	B	CCc1cc(Nc2ncc(F)c(-c3cnc4cccnn34)n2)cc(OCCN2CCC(O)CC2)c1		CHEMBL3823303	=	IC50	nM	8.0	CHEMBL5776	Homo sapiens	IC50	nM	8.0
	16643269	CHEMBL3826094	Inhibition of recombinant TAK1 (unknown origin)	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(C#N)c2)ccc1Oc1ccncc1		CHEMBL3822835	=	IC50	nM	156.0	CHEMBL5776	Homo sapiens	IC50	nM	156.0
	16643270	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	COc1cc(N2CCN(C)CC2)ccc1NC(=O)c1csc2cncnc12		CHEMBL3822538	=	IC50	nM	1300.0	CHEMBL5776	Homo sapiens	IC50	uM	1.3
	16643271	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	COc1cc(C(=O)N2CCN(C)CC2)ccc1NC(=O)c1csc2cncnc12		CHEMBL3822610	=	IC50	nM	1600.0	CHEMBL5776	Homo sapiens	IC50	uM	1.6
	16643272	CHEMBL3826003	Inhibition of GST-tagged TAK1 (unknown origin) expressed in sf9 cells coexpressing His-tagged TAB1 using myelin basic protein as substrate incubated for 30 mins in presence of [33P]ATP by microbeta scintillation counting method	B	COc1cc(C(=O)NCCCN2CCN(C)CC2)ccc1NC(=O)c1csc2cncnc12		CHEMBL3822673	=	IC50	nM	260.0	CHEMBL5776	Homo sapiens	IC50	uM	0.26
	16643273	CHEMBL3826002	Inhibition of TAK1 (unknown origin) at 1 uM by surface plasmon resonance analysis relative to control	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12		CHEMBL3822972	=	Inhibition	%	37.0	CHEMBL5776	Homo sapiens	INH	%	37.0
	16643274	CHEMBL3826558	Inhibition of partial length human wild type TAK1 (M1 to Q303 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CC(C)Oc1c(NC(=O)c2csc3c(=O)[nH]cnc23)cccc1C(=O)N1CCN(C)CC1		CHEMBL3823738	=	Inhibition	%	50.0	CHEMBL5776	Homo sapiens	INH	%	50.0
	16654229	CHEMBL3829763	Inhibition of human TAK1 (1 to 303 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	70.0	CHEMBL5776	Homo sapiens	Activity	%	70.0
	16840451	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	IC50	nM	5.6	CHEMBL5776	Homo sapiens	IC50	nM	5.6
	16840452	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884960	=	IC50	nM	5.1	CHEMBL5776	Homo sapiens	IC50(app)	nM	5.1
	16840453	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	IC50	nM	50.0	CHEMBL5776	Homo sapiens	IC50	nM	50.0
	16840454	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Sc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884813	=	IC50	nM	83.0	CHEMBL5776	Homo sapiens	IC50	nM	83.0
	16840455	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Oc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884569	=	IC50	nM	3.3	CHEMBL5776	Homo sapiens	IC50	nM	3.3
	16840456	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	CCC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884614	>	IC50	nM	10000.0	CHEMBL5776	Homo sapiens	IC50	nM	10000.0
	16840457	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	CCC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884293	=	IC50	nM	1630.0	CHEMBL5776	Homo sapiens	IC50	nM	1630.0
	16840458	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(Oc4ccccc4NC(=O)CCl)n3)cc2)CC1		CHEMBL3883823	=	IC50	nM	25.0	CHEMBL5776	Homo sapiens	IC50	nM	25.0
	16840459	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1cc(NC(C)=O)ccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884222	=	IC50	nM	1640.0	CHEMBL5776	Homo sapiens	IC50	nM	1640.0
	16840460	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1		CHEMBL3884555	=	IC50	nM	950.0	CHEMBL5776	Homo sapiens	IC50	nM	950.0
	16840461	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C		CHEMBL3885038	=	IC50	nM	92.0	CHEMBL5776	Homo sapiens	IC50	nM	92.0
	16840462	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1OC		CHEMBL3883761	=	IC50	nM	75.0	CHEMBL5776	Homo sapiens	IC50	nM	75.0
	16840463	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C1CC1		CHEMBL3884914	=	IC50	nM	57.0	CHEMBL5776	Homo sapiens	IC50	nM	57.0
	16840464	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)nc(N)c1Cl		CHEMBL3884215	=	IC50	nM	2750.0	CHEMBL5776	Homo sapiens	IC50	nM	2750.0
	16840465	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1-n1ccc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21		CHEMBL3885053	=	IC50	nM	3010.0	CHEMBL5776	Homo sapiens	IC50	nM	3010.0
	16840466	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Oc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2OC)ncc1Cl		CHEMBL3885007	=	IC50	nM	342.0	CHEMBL5776	Homo sapiens	IC50	nM	342.0
	16840467	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Oc1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2)ncc1Cl		CHEMBL3884229	=	IC50	nM	4.4	CHEMBL5776	Homo sapiens	IC50	nM	4.4
	16840468	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Oc1ccccc1Nc1nc(Nc2cccc(N3CCOCC3)c2)ncc1Cl		CHEMBL3884616	=	IC50	nM	3.2	CHEMBL5776	Homo sapiens	IC50	nM	3.2
	16840469	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Oc1ccccc1Nc1nc(Nc2cccc(N3CCN(C(C)=O)CC3)c2)ncc1Cl		CHEMBL3885421	=	IC50	nM	1.7	CHEMBL5776	Homo sapiens	IC50	nM	1.7
	16840470	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(C)c2)ncc1Cl		CHEMBL3884143	=	IC50	nM	7.3	CHEMBL5776	Homo sapiens	IC50	nM	7.3
	16840471	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(C(F)F)c2)ncc1Cl		CHEMBL3884642	=	IC50	nM	7.0	CHEMBL5776	Homo sapiens	IC50	nM	7.0
	16840472	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(C3CCOCC3)c2)ncc1Cl		CHEMBL3884281	=	IC50	nM	4.6	CHEMBL5776	Homo sapiens	IC50	nM	4.6
	16840473	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	IC50	nM	2.4	CHEMBL5776	Homo sapiens	IC50	nM	2.4
	16840474	CHEMBL3876688	Inhibition of full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system after 1 hr by TR-FRET based LanthaScreen assay	B	C=CC(=O)Nc1ccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3[nH]ccc23)cc1		CHEMBL3885166	=	IC50	nM	34.0	CHEMBL5776	Homo sapiens	IC50	nM	34.0
Active	16840475	CHEMBL3876687	Binding affinity to full length recombinant human GST-tagged TAK1 expressed in baculovirus expression system assessed as labeling of Cys-174 residue after 1 hr by mass spectrometric analysis	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884960		Activity			CHEMBL5776	Homo sapiens	Activity		
	16840517	CHEMBL3876691	Time-dependent inhibition of TAB1 fused TAK1 (unknown origin) using FAM-LRRKtide as substrate by mobility shift assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884960	=	IC50	nM	360.0	CHEMBL5776	Homo sapiens	IC50	nM	360.0
	16840518	CHEMBL3876691	Time-dependent inhibition of TAB1 fused TAK1 (unknown origin) using FAM-LRRKtide as substrate by mobility shift assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	IC50	nM	125.0	CHEMBL5776	Homo sapiens	IC50	nM	125.0
	16840519	CHEMBL3876691	Time-dependent inhibition of TAB1 fused TAK1 (unknown origin) using FAM-LRRKtide as substrate by mobility shift assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	IC50	nM	7.6	CHEMBL5776	Homo sapiens	IC50	nM	7.6
	16840520	CHEMBL3876691	Time-dependent inhibition of TAB1 fused TAK1 (unknown origin) using FAM-LRRKtide as substrate by mobility shift assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Ki	nM	160.0	CHEMBL5776	Homo sapiens	Ki	nM	160.0
	16840521	CHEMBL3876691	Time-dependent inhibition of TAB1 fused TAK1 (unknown origin) using FAM-LRRKtide as substrate by mobility shift assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Kinact	10'-3/s	1.1	CHEMBL5776	Homo sapiens	Kinact	10'-3/s	1.1
	16840522	CHEMBL3876692	Time-dependent inhibition of TAB1 fused TAK1 (unknown origin) assessed as ratio of Kinact to Ki using FAM-LRRKtide as substrate by mobility shift assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Ratio	10'-6/nM/s	6.87	CHEMBL5776	Homo sapiens	Ratio	10'-6/nM/s	6.87
	16840528	CHEMBL3876700	Inhibition of human TAK1 (M1 to Q303 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	16840529	CHEMBL3876701	Inhibition of human TAK1 (M1 to Q303 residues) expressed in mammalian expression system at 10 uM by KINOMEScan assay	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
	16876009	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(C#N)c12		CHEMBL3901362	=	Inhibition	%	6.0	CHEMBL5776	Homo sapiens	INH	%	6.0
	16876010	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(C(=O)CCl)c12		CHEMBL3905341	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876011	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3953067	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876012	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CNC(=O)/C=C/c1c[nH]c2ncnc(OCC(C)C)c12		CHEMBL3918925	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876013	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	N#C/C=C/c1c[nH]c2ncnc(OCc3ccccc3)c12		CHEMBL3909192	=	Inhibition	%	15.0	CHEMBL5776	Homo sapiens	INH	%	15.0
	16876014	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	NC(=O)/C=C/c1c[nH]c2ncnc(OCc3ccccc3)c12		CHEMBL3891089	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876015	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CCC(=O)/C=C/c1c[nH]c2ncnc(OCC(C)C)c12		CHEMBL3893882	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876016	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	COC(=O)/C=C/c1c[nH]c2ncnc(OCC(C)C)c12		CHEMBL3922526	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876017	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	COC(=O)/C(C)=C/c1c[nH]c2ncnc(OCC(C)C)c12		CHEMBL3925269	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876018	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)O)c12		CHEMBL3975493	=	Inhibition	%	1.0	CHEMBL5776	Homo sapiens	INH	%	1.0
	16876019	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CCNC(=O)/C=C/c1c[nH]c2ncnc(OCC(C)C)c12		CHEMBL3919844	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876020	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)NCC3CC3)c12		CHEMBL3929132	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876021	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)NC3CC3)c12		CHEMBL3934288	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876022	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)NC[C@H](C)O)c12		CHEMBL3945840	=	Inhibition	%	1.0	CHEMBL5776	Homo sapiens	INH	%	1.0
	16876023	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)NC[C@@H](C)O)c12		CHEMBL3901598	=	Inhibition	%	1.0	CHEMBL5776	Homo sapiens	INH	%	1.0
	16876024	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)N(C)C)c12		CHEMBL3919897	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876025	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(C#CC(N)=O)c12		CHEMBL3917140	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876026	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CCC(C)Oc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3916326	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876027	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)Oc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3924740	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876028	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CCCOc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3905384	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876029	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	NC(=O)/C=C/c1c[nH]c2ncnc(Oc3ccccc3)c12		CHEMBL3902720	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876030	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	NC(=O)/C=C/c1c[nH]c2ncnc(OCC(F)(F)F)c12		CHEMBL3901893	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876031	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)(C)COc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3919781	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876032	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)(O)COc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3895287	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876033	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	NC(=O)/C=C/c1c[nH]c2ncnc(OCc3cccc(F)c3)c12		CHEMBL3969384	=	Inhibition	%	1.0	CHEMBL5776	Homo sapiens	INH	%	1.0
	16876034	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)(C)Oc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3898170	=	Inhibition	%	1.0	CHEMBL5776	Homo sapiens	INH	%	1.0
	16876035	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C(\Cl)C(N)=O)c12		CHEMBL3973552	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876036	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	C=C(C#N)c1c[nH]c2ncnc(OCC(C)C)c12		CHEMBL3907201	=	Inhibition	%	75.0	CHEMBL5776	Homo sapiens	INH	%	75.0
	16876037	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(C/C=C/C(N)=O)c12		CHEMBL3912629	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876038	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	NC(=O)/C=C/c1c[nH]c2ncnc(OC3CCC(F)(F)CC3)c12		CHEMBL3912681	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876039	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C(\F)C(N)=O)c12		CHEMBL3897133	=	Inhibition	%	14.0	CHEMBL5776	Homo sapiens	INH	%	14.0
	16876040	CHEMBL3880355	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 50 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	COC(=O)/C=C/c1c[nH]c2ncnc(OCc3ccccc3)c12		CHEMBL3895447	=	Inhibition	%	1.0	CHEMBL5776	Homo sapiens	INH	%	1.0
	16876041	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(C#N)c12		CHEMBL3901362	=	Inhibition	%	83.0	CHEMBL5776	Homo sapiens	INH	%	83.0
	16876042	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(C(=O)CCl)c12		CHEMBL3905341	=	Inhibition	%	117.0	CHEMBL5776	Homo sapiens	INH	%	117.0
	16876043	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3953067	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876044	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CNC(=O)/C=C/c1c[nH]c2ncnc(OCC(C)C)c12		CHEMBL3918925	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876045	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	N#C/C=C/c1c[nH]c2ncnc(OCc3ccccc3)c12		CHEMBL3909192	=	Inhibition	%	21.0	CHEMBL5776	Homo sapiens	INH	%	21.0
	16876046	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	NC(=O)/C=C/c1c[nH]c2ncnc(OCc3ccccc3)c12		CHEMBL3891089	=	Inhibition	%	78.0	CHEMBL5776	Homo sapiens	INH	%	78.0
	16876047	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CCC(=O)/C=C/c1c[nH]c2ncnc(OCC(C)C)c12		CHEMBL3893882	=	Inhibition	%	3.0	CHEMBL5776	Homo sapiens	INH	%	3.0
	16876048	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	COC(=O)/C=C/c1c[nH]c2ncnc(OCC(C)C)c12		CHEMBL3922526	=	Inhibition	%	1.0	CHEMBL5776	Homo sapiens	INH	%	1.0
	16876049	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	COC(=O)/C(C)=C/c1c[nH]c2ncnc(OCC(C)C)c12		CHEMBL3925269	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876050	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)O)c12		CHEMBL3975493	=	Inhibition	%	68.0	CHEMBL5776	Homo sapiens	INH	%	68.0
	16876051	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CCNC(=O)/C=C/c1c[nH]c2ncnc(OCC(C)C)c12		CHEMBL3919844	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876052	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)NCC3CC3)c12		CHEMBL3929132	=	Inhibition	%	2.0	CHEMBL5776	Homo sapiens	INH	%	2.0
	16876053	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)NC3CC3)c12		CHEMBL3934288	=	Inhibition	%	1.0	CHEMBL5776	Homo sapiens	INH	%	1.0
	16876054	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)NC[C@H](C)O)c12		CHEMBL3945840	=	Inhibition	%	36.0	CHEMBL5776	Homo sapiens	INH	%	36.0
	16876055	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)NC[C@@H](C)O)c12		CHEMBL3901598	=	Inhibition	%	78.0	CHEMBL5776	Homo sapiens	INH	%	78.0
	16876056	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)N(C)C)c12		CHEMBL3919897	=	Inhibition	%	1.0	CHEMBL5776	Homo sapiens	INH	%	1.0
	16876057	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(C#CC(N)=O)c12		CHEMBL3917140	=	Inhibition	%	1.0	CHEMBL5776	Homo sapiens	INH	%	1.0
	16876058	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CCC(C)Oc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3916326	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876059	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)Oc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3924740	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876060	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CCCOc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3905384	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876061	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	NC(=O)/C=C/c1c[nH]c2ncnc(Oc3ccccc3)c12		CHEMBL3902720	=	Inhibition	%	15.0	CHEMBL5776	Homo sapiens	INH	%	15.0
	16876062	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	NC(=O)/C=C/c1c[nH]c2ncnc(OCC(F)(F)F)c12		CHEMBL3901893	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876063	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)(C)COc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3919781	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876064	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)(O)COc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3895287	=	Inhibition	%	22.0	CHEMBL5776	Homo sapiens	INH	%	22.0
	16876065	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	NC(=O)/C=C/c1c[nH]c2ncnc(OCc3cccc(F)c3)c12		CHEMBL3969384	=	Inhibition	%	1.0	CHEMBL5776	Homo sapiens	INH	%	1.0
	16876066	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)(C)Oc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3898170	=	Inhibition	%	19.0	CHEMBL5776	Homo sapiens	INH	%	19.0
	16876067	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C(\Cl)C(N)=O)c12		CHEMBL3973552	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876068	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	C=C(C#N)c1c[nH]c2ncnc(OCC(C)C)c12		CHEMBL3907201	=	Inhibition	%	128.0	CHEMBL5776	Homo sapiens	INH	%	128.0
	16876069	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(C/C=C/C(N)=O)c12		CHEMBL3912629	=	Inhibition	%	4.0	CHEMBL5776	Homo sapiens	INH	%	4.0
	16876070	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	NC(=O)/C=C/c1c[nH]c2ncnc(OC3CCC(F)(F)CC3)c12		CHEMBL3912681	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	16876071	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	CC(C)COc1ncnc2[nH]cc(/C=C(\F)C(N)=O)c12		CHEMBL3897133	=	Inhibition	%	61.0	CHEMBL5776	Homo sapiens	INH	%	61.0
	16876072	CHEMBL3880357	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production at 5 uM preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs relative to control	B	COC(=O)/C=C/c1c[nH]c2ncnc(OCc3ccccc3)c12		CHEMBL3895447	=	Inhibition	%	26.0	CHEMBL5776	Homo sapiens	INH	%	26.0
	16876073	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CC(C)COc1ncnc2[nH]cc(C(=O)CCl)c12		CHEMBL3905341	=	IC50	nM	12000.0	CHEMBL5776	Homo sapiens	IC50	uM	12.0
	16876074	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3953067	=	IC50	nM	85.0	CHEMBL5776	Homo sapiens	IC50	uM	0.085
	16876075	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CNC(=O)/C=C/c1c[nH]c2ncnc(OCC(C)C)c12		CHEMBL3918925	=	IC50	nM	43.0	CHEMBL5776	Homo sapiens	IC50	uM	0.043
	16876076	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	N#C/C=C/c1c[nH]c2ncnc(OCc3ccccc3)c12		CHEMBL3909192	=	IC50	nM	2200.0	CHEMBL5776	Homo sapiens	IC50	uM	2.2
	16876077	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CCC(=O)/C=C/c1c[nH]c2ncnc(OCC(C)C)c12		CHEMBL3893882	=	IC50	nM	990.0	CHEMBL5776	Homo sapiens	IC50	uM	0.99
	16876078	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	COC(=O)/C(C)=C/c1c[nH]c2ncnc(OCC(C)C)c12		CHEMBL3925269	=	IC50	nM	620.0	CHEMBL5776	Homo sapiens	IC50	uM	0.62
	16876079	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CCNC(=O)/C=C/c1c[nH]c2ncnc(OCC(C)C)c12		CHEMBL3919844	=	IC50	nM	87.0	CHEMBL5776	Homo sapiens	IC50	uM	0.087
	16876080	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)NCC3CC3)c12		CHEMBL3929132	=	IC50	nM	630.0	CHEMBL5776	Homo sapiens	IC50	uM	0.63
	16876081	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)NC3CC3)c12		CHEMBL3934288	=	IC50	nM	180.0	CHEMBL5776	Homo sapiens	IC50	uM	0.18
	16876082	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)NC[C@H](C)O)c12		CHEMBL3945840	=	IC50	nM	3400.0	CHEMBL5776	Homo sapiens	IC50	uM	3.4
	16876083	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)NC[C@@H](C)O)c12		CHEMBL3901598	=	IC50	nM	12000.0	CHEMBL5776	Homo sapiens	IC50	uM	12.0
	16876084	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CC(C)COc1ncnc2[nH]cc(/C=C/C(=O)N(C)C)c12		CHEMBL3919897	=	IC50	nM	190.0	CHEMBL5776	Homo sapiens	IC50	uM	0.19
	16876085	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CC(C)COc1ncnc2[nH]cc(C#CC(N)=O)c12		CHEMBL3917140	=	IC50	nM	850.0	CHEMBL5776	Homo sapiens	IC50	uM	0.85
	16876086	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CCC(C)Oc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3916326	=	IC50	nM	190.0	CHEMBL5776	Homo sapiens	IC50	uM	0.19
	16876087	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CC(C)Oc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3924740	=	IC50	nM	170.0	CHEMBL5776	Homo sapiens	IC50	uM	0.17
	16876088	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CCCOc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3905384	=	IC50	nM	180.0	CHEMBL5776	Homo sapiens	IC50	uM	0.18
	16876089	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	NC(=O)/C=C/c1c[nH]c2ncnc(Oc3ccccc3)c12		CHEMBL3902720	=	IC50	nM	1000.0	CHEMBL5776	Homo sapiens	IC50	uM	1.0
	16876090	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	NC(=O)/C=C/c1c[nH]c2ncnc(OCC(F)(F)F)c12		CHEMBL3901893	=	IC50	nM	150.0	CHEMBL5776	Homo sapiens	IC50	uM	0.15
	16876091	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CC(C)(C)COc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3919781	=	IC50	nM	78.0	CHEMBL5776	Homo sapiens	IC50	uM	0.078
	16876092	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CC(C)(O)COc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3895287	=	IC50	nM	1200.0	CHEMBL5776	Homo sapiens	IC50	uM	1.2
	16876093	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	NC(=O)/C=C/c1c[nH]c2ncnc(OCc3cccc(F)c3)c12		CHEMBL3969384	=	IC50	nM	43.0	CHEMBL5776	Homo sapiens	IC50	uM	0.043
	16876094	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CC(C)(C)Oc1ncnc2[nH]cc(/C=C/C(N)=O)c12		CHEMBL3898170	=	IC50	nM	920.0	CHEMBL5776	Homo sapiens	IC50	uM	0.92
	16876095	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CC(C)COc1ncnc2[nH]cc(/C=C(\Cl)C(N)=O)c12		CHEMBL3973552	=	IC50	nM	750.0	CHEMBL5776	Homo sapiens	IC50	uM	0.75
	16876096	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	CC(C)COc1ncnc2[nH]cc(C/C=C/C(N)=O)c12		CHEMBL3912629	=	IC50	nM	8400.0	CHEMBL5776	Homo sapiens	IC50	uM	8.4
	16876097	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	NC(=O)/C=C/c1c[nH]c2ncnc(OC3CCC(F)(F)CC3)c12		CHEMBL3912681	=	IC50	nM	180.0	CHEMBL5776	Homo sapiens	IC50	uM	0.18
	16876098	CHEMBL3880358	Inhibition of TAK1 in human A549 cells assessed as decrease in recombinant human IL-1beta-stimulated IL6 production preincubated for 3 hrs followed by IL-1beta stimulation measured after 18 hrs	B	COC(=O)/C=C/c1c[nH]c2ncnc(OCc3ccccc3)c12		CHEMBL3895447	=	IC50	nM	800.0	CHEMBL5776	Homo sapiens	IC50	uM	0.8
	17964954	CHEMBL3995067	Inhibition of human TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	100.0	CHEMBL5776	Homo sapiens	Activity	%	100.0
	17982184	CHEMBL3998815	Inhibition of human TAK1 at 1 uM using casein as substrate in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	Inhibition	%	80.0	CHEMBL5776	Homo sapiens	INH	%	80.0
	18012354	CHEMBL4004189	Binding affinity to recombinant human biotinylated N-terminal GST-tagged autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells by SPR assay	B	CN1CCN(c2cccc3cc(NC(=O)Nc4ccc(Oc5ccnc6[nH]ccc56)cc4)ccc23)CC1		CHEMBL4095421	=	Kd	nM	12.0	CHEMBL5776	Homo sapiens	Kd	uM	0.012
	18012355	CHEMBL4004189	Binding affinity to recombinant human biotinylated N-terminal GST-tagged autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells by SPR assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	600.0	CHEMBL5776	Homo sapiens	Kd	uM	0.6
	18012356	CHEMBL4004189	Binding affinity to recombinant human biotinylated N-terminal GST-tagged autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells by SPR assay	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12		CHEMBL3822972	=	Kd	nM	59.0	CHEMBL5776	Homo sapiens	Kd	uM	0.059
	18012357	CHEMBL4004189	Binding affinity to recombinant human biotinylated N-terminal GST-tagged autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells by SPR assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL477	=	Kd	nM	4400.0	CHEMBL5776	Homo sapiens	Kd	uM	4.4
	18012358	CHEMBL4004189	Binding affinity to recombinant human biotinylated N-terminal GST-tagged autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells by SPR assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL752	=	Kd	nM	120000.0	CHEMBL5776	Homo sapiens	Kd	uM	120.0
	18012359	CHEMBL4004189	Binding affinity to recombinant human biotinylated N-terminal GST-tagged autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells by SPR assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL14830	=	Kd	nM	4100.0	CHEMBL5776	Homo sapiens	Kd	uM	4.1
	18012360	CHEMBL4004189	Binding affinity to recombinant human biotinylated N-terminal GST-tagged autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells by SPR assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL14249	=	Kd	nM	2800.0	CHEMBL5776	Homo sapiens	Kd	uM	2.8
Active	18012361	CHEMBL4004188	Binding affinity to recombinant human biotinylated N-terminal GST-tagged TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells at 100 nM in presence of ATP by SPR assay	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979		Activity			CHEMBL5776	Homo sapiens	Activity		
	18012362	CHEMBL4004190	Binding affinity to recombinant human biotinylated N-terminal GST-tagged non-autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells by SPR assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL14830	=	Kd	nM	63000.0	CHEMBL5776	Homo sapiens	Kd	uM	63.0
	18012363	CHEMBL4004190	Binding affinity to recombinant human biotinylated N-terminal GST-tagged non-autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells by SPR assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL752	=	Kd	nM	370000.0	CHEMBL5776	Homo sapiens	Kd	uM	370.0
	18012364	CHEMBL4004190	Binding affinity to recombinant human biotinylated N-terminal GST-tagged non-autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells by SPR assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL477	=	Kd	nM	34000.0	CHEMBL5776	Homo sapiens	Kd	uM	34.0
	18012365	CHEMBL4004190	Binding affinity to recombinant human biotinylated N-terminal GST-tagged non-autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells by SPR assay	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12		CHEMBL3822972	=	Kd	nM	150.0	CHEMBL5776	Homo sapiens	Kd	uM	0.15
	18012366	CHEMBL4004190	Binding affinity to recombinant human biotinylated N-terminal GST-tagged non-autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells by SPR assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	1300.0	CHEMBL5776	Homo sapiens	Kd	uM	1.3
	18012367	CHEMBL4004191	Binding affinity to recombinant human biotinylated N-terminal GST-tagged autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells assessed as association rate constant by SPR assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1	Non standard unit for type	CHEMBL1336	=	K	10'4/M/s	1.4	CHEMBL5776	Homo sapiens	K	10'4/M/s	1.4
	18012368	CHEMBL4004191	Binding affinity to recombinant human biotinylated N-terminal GST-tagged autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells assessed as association rate constant by SPR assay	B	CN1CCN(c2cccc3cc(NC(=O)Nc4ccc(Oc5ccnc6[nH]ccc56)cc4)ccc23)CC1	Non standard unit for type	CHEMBL4095421	=	K	10'4/M/s	6.6	CHEMBL5776	Homo sapiens	K	10'4/M/s	6.6
	18012369	CHEMBL4004192	Binding affinity to recombinant human biotinylated N-terminal GST-tagged non-autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells assessed as association rate constant by SPR assay	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12	Non standard unit for type	CHEMBL3822972	=	K	10'5/M/s	5.8	CHEMBL5776	Homo sapiens	K	10'5/M/s	5.8
	18012370	CHEMBL4004192	Binding affinity to recombinant human biotinylated N-terminal GST-tagged non-autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells assessed as association rate constant by SPR assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1	Non standard unit for type	CHEMBL1336	=	K	10'3/M/s	9.6	CHEMBL5776	Homo sapiens	K	10'3/M/s	9.6
	18012371	CHEMBL4004193	Binding affinity to recombinant human biotinylated N-terminal GST-tagged autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells assessed as dissociation rate constant by SPR assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1	Non standard unit for type	CHEMBL1336	=	K	/s	0.018	CHEMBL5776	Homo sapiens	K	/s	0.018
	18012372	CHEMBL4004193	Binding affinity to recombinant human biotinylated N-terminal GST-tagged autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells assessed as dissociation rate constant by SPR assay	B	CN1CCN(c2cccc3cc(NC(=O)Nc4ccc(Oc5ccnc6[nH]ccc56)cc4)ccc23)CC1	Non standard unit for type	CHEMBL4095421	=	K	/s	0.00079	CHEMBL5776	Homo sapiens	K	/s	0.00079
	18012373	CHEMBL4004194	Binding affinity to recombinant human biotinylated N-terminal GST-tagged non-autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells assessed as dissociation rate constant by SPR assay	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12	Non standard unit for type	CHEMBL3822972	=	K	/s	0.034	CHEMBL5776	Homo sapiens	K	/s	0.034
	18012374	CHEMBL4004194	Binding affinity to recombinant human biotinylated N-terminal GST-tagged non-autophosphorylated TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells assessed as dissociation rate constant by SPR assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1	Non standard unit for type	CHEMBL1336	=	K	/s	0.0058	CHEMBL5776	Homo sapiens	K	/s	0.0058
	18012375	CHEMBL4004195	Inhibition of recombinant human GST-tagged TAK1 (1 to 303 residues) fused with His-tagged TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells at 1 uM using myelin basic protein as substrate in presence of [33P]ATP after 30 mins by microbeta liquid scintillation counting method relative to control	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12		CHEMBL3822972	=	Inhibition	%	37.0	CHEMBL5776	Homo sapiens	INH	%	37.0
Active	18012379	CHEMBL4004199	Binding affinity to recombinant human biotinylated N-terminal GST-tagged TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells at 1 uM in presence of ATP by SPR assay	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12		CHEMBL3822972		Activity			CHEMBL5776	Homo sapiens	Activity		
Active	18012380	CHEMBL4004200	Binding affinity to recombinant human biotinylated N-terminal GST-tagged TAK1 (1 to 303 residues) fused with TAB1 (437 to 504 residues) expressed in baculovirus infected sf9 cells at 250 uM in presence of ATP by SPR assay	B	Oc1cnnc(SCc2ccc(Br)cc2)n1		CHEMBL4074147		Activity			CHEMBL5776	Homo sapiens	Activity		
Active	18012381	CHEMBL4004201	Binding affinity to TAK1 (unknown origin) at 5 uM using spin-labeled probe by 1H NMR method	B	Oc1cnnc(SCc2ccc(Br)cc2)n1		CHEMBL4074147		Activity			CHEMBL5776	Homo sapiens	Activity		
	18048607	CHEMBL4011060	Inhibition of TNFalpha-stimulated TAK1 in human U937 cells assessed as residual activity at 10 uM in presence of ATP relative to control	B	S=C(NCc1ccccc1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL4088718	=	Activity	%	106.0	CHEMBL5776	Homo sapiens	Activity	%	106.0
Not Active	18091341	CHEMBL4019850	Inhibition of TAK1 (unknown origin) at 10 uM	B	O/N=c1\cc(-c2cc3cccn3cn2)oc2ccc(OCCN3CCOCC3)cc12		CHEMBL4067875		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
	18114872	CHEMBL4025402	Inhibition of wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	89.0	CHEMBL5776	Homo sapiens	Activity	%	89.0
	18153216	CHEMBL4034502	Inhibition of TAK1 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	9.6	CHEMBL5776	Homo sapiens	INH	%	9.6
	18203926	CHEMBL4044213	Inhibition of wild-type human partial length TAK1 (M1 to Q303 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL5776	Homo sapiens	Activity	%	100.0
	18211751	CHEMBL4045847	Inhibition of TAK1 conserved Lys2 (DLKPPNLLLVAGGTVLK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-18.1	CHEMBL5776	Homo sapiens	INH	%	-18.1
	18211992	CHEMBL4046088	Inhibition of TAK1 conserved Lys2 (DLKPPNLLLVAGGTVLK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-0.4	CHEMBL5776	Homo sapiens	INH	%	-0.4
	18232170	CHEMBL4050336	Inhibition of human TAK1 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	80.0	CHEMBL5776	Homo sapiens	Activity	%	80.0
	18253299	CHEMBL4054933	Inhibition of wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	48.0	CHEMBL5776	Homo sapiens	Activity	%	48.0
	18253300	CHEMBL4054933	Inhibition of wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	73.0	CHEMBL5776	Homo sapiens	Activity	%	73.0
	18265949	CHEMBL4057399	Inhibition of c-TAK1 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	15.0	CHEMBL5776	Homo sapiens	INH	%	15.0
	18266165	CHEMBL4057615	Inhibition of c-TAK1 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	6.0	CHEMBL5776	Homo sapiens	INH	%	6.0
	18266215	CHEMBL4057665	Inhibition of c-TAK1 (unknown origin) at 0.078 uM relative to control	B	COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12		CHEMBL4066592	=	Inhibition	%	-3.3	CHEMBL5776	Homo sapiens	INH	%	-3.3
	18275301	CHEMBL4118479	Inhibition of TAK1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPPNLLLVAGGTVLK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	90.3	CHEMBL5776	Homo sapiens	INH	%	90.3
	18275302	CHEMBL4118479	Inhibition of TAK1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPPNLLLVAGGTVLK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	31.2	CHEMBL5776	Homo sapiens	INH	%	31.2
	18275303	CHEMBL4118479	Inhibition of TAK1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DLKPPNLLLVAGGTVLK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	90.0	CHEMBL5776	Homo sapiens	INH	%	90.0
	18275385	CHEMBL4118519	Inhibition of human TAK1 (1 to 303 residues) expressed in mammalian expression system assessed as enzyme activity at 1 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	58.0	CHEMBL5776	Homo sapiens	Activity	%	58.0
	18275389	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884960	=	IC50	nM	5.1	CHEMBL5776	Homo sapiens	IC50	nM	5.1
	18275390	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	IC50	nM	50.0	CHEMBL5776	Homo sapiens	IC50	nM	50.0
	18275391	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Sc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884813	=	IC50	nM	83.0	CHEMBL5776	Homo sapiens	IC50	nM	83.0
	18275392	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Oc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884569	=	IC50	nM	3.3	CHEMBL5776	Homo sapiens	IC50	nM	3.3
	18275393	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	CCC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Non standard unit for type	CHEMBL3884614	>	IC50	10'-4nM	1.0	CHEMBL5776	Homo sapiens	IC50	10'-4nM	1.0
	18275394	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	CCC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884293	=	IC50	nM	1630.0	CHEMBL5776	Homo sapiens	IC50	nM	1630.0
	18275395	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccccc4NC(=O)CCl)n3)cc2)CC1		CHEMBL4128584	=	IC50	nM	25.0	CHEMBL5776	Homo sapiens	IC50	nM	25.0
	18275396	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Nc1cc(NC(C)=O)ccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL4129949	=	IC50	nM	1640.0	CHEMBL5776	Homo sapiens	IC50	nM	1640.0
	18275397	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)n1		CHEMBL3884555	=	IC50	nM	950.0	CHEMBL5776	Homo sapiens	IC50	nM	950.0
	18275398	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C		CHEMBL3885038	=	IC50	nM	92.0	CHEMBL5776	Homo sapiens	IC50	nM	92.0
	18275399	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1OC		CHEMBL3883761	=	IC50	nM	75.0	CHEMBL5776	Homo sapiens	IC50	nM	75.0
	18275400	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C1CC1		CHEMBL3884914	=	IC50	nM	57.0	CHEMBL5776	Homo sapiens	IC50	nM	57.0
	18275401	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)nc(N)c1Cl		CHEMBL3884215	=	IC50	nM	2750.0	CHEMBL5776	Homo sapiens	IC50	nM	2750.0
	18275402	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Nc1ccccc1-n1ccc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc21		CHEMBL3885053	=	IC50	nM	3010.0	CHEMBL5776	Homo sapiens	IC50	nM	3010.0
	18275403	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Oc1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2)ncc1Cl		CHEMBL3884229	=	IC50	nM	4.4	CHEMBL5776	Homo sapiens	IC50	nM	4.4
	18275404	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Oc1ccccc1Nc1nc(Nc2cccc(N3CCOCC3)c2)ncc1Cl		CHEMBL3884616	=	IC50	nM	3.2	CHEMBL5776	Homo sapiens	IC50	nM	3.2
	18275405	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Oc1ccccc1Nc1nc(Nc2cccc(N3CCN(C(C)=O)CC3)c2)ncc1Cl		CHEMBL3885421	=	IC50	nM	1.7	CHEMBL5776	Homo sapiens	IC50	nM	1.7
	18275406	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(C)c2)ncc1Cl		CHEMBL3884143	=	IC50	nM	7.3	CHEMBL5776	Homo sapiens	IC50	nM	7.3
	18275407	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(C(F)F)c2)ncc1Cl		CHEMBL3884642	=	IC50	nM	7.0	CHEMBL5776	Homo sapiens	IC50	nM	7.0
	18275408	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(C3CCOCC3)c2)ncc1Cl		CHEMBL3884281	=	IC50	nM	4.6	CHEMBL5776	Homo sapiens	IC50	nM	4.6
	18275409	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	IC50	nM	2.4	CHEMBL5776	Homo sapiens	IC50	nM	2.4
	18275410	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	CCC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL4127488	=	IC50	nM	1230.0	CHEMBL5776	Homo sapiens	IC50	nM	1230.0
	18275411	CHEMBL4118523	Inhibition of TAK1 (unknown origin) by LanthaScreen assay	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	IC50	nM	5.6	CHEMBL5776	Homo sapiens	IC50	nM	5.6
	18275558	CHEMBL4118538	Inhibition of TAK1 (unknown origin) after 60 mins by biochemical assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274	=	IC50	nM	33.0	CHEMBL5776	Homo sapiens	IC50	nM	33.0
Active	18275559	CHEMBL4118539	Inhibition of biotin-labeled N-(2-(2-(2-(2-(4-(4-((4-((2-Acrylamidophenyl)amino)-5-chloropyrimidin-2-yl)amino)phenyl)piperazin-1-yl)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide probe binding to TAK1 in human NCI-H358 cells at 1 uM after 6 hrs by immunoblot based competitive pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18275560	CHEMBL4118539	Inhibition of biotin-labeled N-(2-(2-(2-(2-(4-(4-((4-((2-Acrylamidophenyl)amino)-5-chloropyrimidin-2-yl)amino)phenyl)piperazin-1-yl)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide probe binding to TAK1 in human NCI-H358 cells at 1 uM after 6 hrs by immunoblot based competitive pull down assay	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18275561	CHEMBL4118539	Inhibition of biotin-labeled N-(2-(2-(2-(2-(4-(4-((4-((2-Acrylamidophenyl)amino)-5-chloropyrimidin-2-yl)amino)phenyl)piperazin-1-yl)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide probe binding to TAK1 in human NCI-H358 cells at 1 uM after 6 hrs by immunoblot based competitive pull down assay	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(Oc4ccnc5[nH]ccc45)c3)cc2C(F)(F)F)CC1		CHEMBL4125960		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18275562	CHEMBL4118540	Inhibition of biotin-labeled N-(2-(2-(2-(2-(4-(4-((4-((2-Acrylamidophenyl)amino)-5-chloropyrimidin-2-yl)amino)phenyl)piperazin-1-yl)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide probe binding to TAK1 in human NCI-H358 cells at 10 uM after 6 hrs by immunoblot based competitive pull down assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884960		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Not Active	18275563	CHEMBL4118540	Inhibition of biotin-labeled N-(2-(2-(2-(2-(4-(4-((4-((2-Acrylamidophenyl)amino)-5-chloropyrimidin-2-yl)amino)phenyl)piperazin-1-yl)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide probe binding to TAK1 in human NCI-H358 cells at 10 uM after 6 hrs by immunoblot based competitive pull down assay	B	CCC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884614		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Not Active	18275564	CHEMBL4118540	Inhibition of biotin-labeled N-(2-(2-(2-(2-(4-(4-((4-((2-Acrylamidophenyl)amino)-5-chloropyrimidin-2-yl)amino)phenyl)piperazin-1-yl)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide probe binding to TAK1 in human NCI-H358 cells at 10 uM after 6 hrs by immunoblot based competitive pull down assay	B	CCC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884293		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18275565	CHEMBL4118540	Inhibition of biotin-labeled N-(2-(2-(2-(2-(4-(4-((4-((2-Acrylamidophenyl)amino)-5-chloropyrimidin-2-yl)amino)phenyl)piperazin-1-yl)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide probe binding to TAK1 in human NCI-H358 cells at 10 uM after 6 hrs by immunoblot based competitive pull down assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccccc4NC(=O)CCl)n3)cc2)CC1		CHEMBL4128584		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18275566	CHEMBL4118540	Inhibition of biotin-labeled N-(2-(2-(2-(2-(4-(4-((4-((2-Acrylamidophenyl)amino)-5-chloropyrimidin-2-yl)amino)phenyl)piperazin-1-yl)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide probe binding to TAK1 in human NCI-H358 cells at 10 uM after 6 hrs by immunoblot based competitive pull down assay	B	C=CC(=O)Oc1ccccc1Nc1nc(Nc2cccc(N3CCOCC3)c2)ncc1Cl		CHEMBL3884616		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18275567	CHEMBL4118540	Inhibition of biotin-labeled N-(2-(2-(2-(2-(4-(4-((4-((2-Acrylamidophenyl)amino)-5-chloropyrimidin-2-yl)amino)phenyl)piperazin-1-yl)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide probe binding to TAK1 in human NCI-H358 cells at 10 uM after 6 hrs by immunoblot based competitive pull down assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(C(F)F)c2)ncc1Cl		CHEMBL3884642		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18275568	CHEMBL4118540	Inhibition of biotin-labeled N-(2-(2-(2-(2-(4-(4-((4-((2-Acrylamidophenyl)amino)-5-chloropyrimidin-2-yl)amino)phenyl)piperazin-1-yl)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide probe binding to TAK1 in human NCI-H358 cells at 10 uM after 6 hrs by immunoblot based competitive pull down assay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Not Active	18275569	CHEMBL4118540	Inhibition of biotin-labeled N-(2-(2-(2-(2-(4-(4-((4-((2-Acrylamidophenyl)amino)-5-chloropyrimidin-2-yl)amino)phenyl)piperazin-1-yl)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide probe binding to TAK1 in human NCI-H358 cells at 10 uM after 6 hrs by immunoblot based competitive pull down assay	B	CCC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL4127488		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18275643	CHEMBL4118603	Binding affinity to MAP3K7 in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL5776	Homo sapiens	Activity		
Active	18275872	CHEMBL4118832	Binding affinity to MAP3K7 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL5776	Homo sapiens	Activity		
Active	18276098	CHEMBL4119058	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of TNFalpha-induced cytokine secretion at 0.6 uM preincubated for 3 hrs followed by TNFalpha stimulation measured after 18 hrs by sandwich immunoassay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18276099	CHEMBL4119058	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of TNFalpha-induced cytokine secretion at 0.6 uM preincubated for 3 hrs followed by TNFalpha stimulation measured after 18 hrs by sandwich immunoassay	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18276100	CHEMBL4119059	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of IL-1alpha-induced cytokine secretion at 0.6 uM preincubated for 3 hrs followed by IL-1alpha stimulation measured after 18 hrs by sandwich immunoassay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18276101	CHEMBL4119059	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of IL-1alpha-induced cytokine secretion at 0.6 uM preincubated for 3 hrs followed by IL-1alpha stimulation measured after 18 hrs by sandwich immunoassay	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18276102	CHEMBL4119060	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of poly(I:C)-induced cytokine secretion at 0.6 uM preincubated for 3 hrs followed by poly(I:C) stimulation measured after 18 hrs by sandwich immunoassay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18276103	CHEMBL4119060	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of poly(I:C)-induced cytokine secretion at 0.6 uM preincubated for 3 hrs followed by poly(I:C) stimulation measured after 18 hrs by sandwich immunoassay	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18276104	CHEMBL4119061	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of TNFalpha-induced cytokine secretion at 3 uM preincubated for 3 hrs followed by TNFalpha stimulation measured after 18 hrs by sandwich immunoassay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884960		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Not Active	18276105	CHEMBL4119061	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of TNFalpha-induced cytokine secretion at 3 uM preincubated for 3 hrs followed by TNFalpha stimulation measured after 18 hrs by sandwich immunoassay	B	CCC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884614		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18276106	CHEMBL4119061	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of TNFalpha-induced cytokine secretion at 3 uM preincubated for 3 hrs followed by TNFalpha stimulation measured after 18 hrs by sandwich immunoassay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Not Active	18276107	CHEMBL4119061	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of TNFalpha-induced cytokine secretion at 3 uM preincubated for 3 hrs followed by TNFalpha stimulation measured after 18 hrs by sandwich immunoassay	B	CCC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL4127488		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18276108	CHEMBL4119061	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of TNFalpha-induced cytokine secretion at 3 uM preincubated for 3 hrs followed by TNFalpha stimulation measured after 18 hrs by sandwich immunoassay	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(Oc4ccnc5[nH]ccc45)c3)cc2C(F)(F)F)CC1		CHEMBL4125960		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18276109	CHEMBL4119062	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of IL-1alpha-induced cytokine secretion at 3 uM preincubated for 3 hrs followed by IL-1alpha stimulation measured after 18 hrs by sandwich immunoassay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884960		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Not Active	18276110	CHEMBL4119062	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of IL-1alpha-induced cytokine secretion at 3 uM preincubated for 3 hrs followed by IL-1alpha stimulation measured after 18 hrs by sandwich immunoassay	B	CCC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884614		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18276111	CHEMBL4119062	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of IL-1alpha-induced cytokine secretion at 3 uM preincubated for 3 hrs followed by IL-1alpha stimulation measured after 18 hrs by sandwich immunoassay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Not Active	18276112	CHEMBL4119062	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of IL-1alpha-induced cytokine secretion at 3 uM preincubated for 3 hrs followed by IL-1alpha stimulation measured after 18 hrs by sandwich immunoassay	B	CCC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL4127488		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18276113	CHEMBL4119062	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of IL-1alpha-induced cytokine secretion at 3 uM preincubated for 3 hrs followed by IL-1alpha stimulation measured after 18 hrs by sandwich immunoassay	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(Oc4ccnc5[nH]ccc45)c3)cc2C(F)(F)F)CC1		CHEMBL4125960		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18276114	CHEMBL4119063	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of poly(I:C)-induced cytokine secretion at 3 uM preincubated for 3 hrs followed by poly(I:C) stimulation measured after 18 hrs by sandwich immunoassay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884960		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Not Active	18276115	CHEMBL4119063	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of poly(I:C)-induced cytokine secretion at 3 uM preincubated for 3 hrs followed by poly(I:C) stimulation measured after 18 hrs by sandwich immunoassay	B	CCC(=O)Nc1ccccc1Oc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3884614		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18276116	CHEMBL4119063	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of poly(I:C)-induced cytokine secretion at 3 uM preincubated for 3 hrs followed by poly(I:C) stimulation measured after 18 hrs by sandwich immunoassay	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Not Active	18276117	CHEMBL4119063	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of poly(I:C)-induced cytokine secretion at 3 uM preincubated for 3 hrs followed by poly(I:C) stimulation measured after 18 hrs by sandwich immunoassay	B	CCC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL4127488		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	18276118	CHEMBL4119063	Inhibition of TAK1 in RA patient-derived synovial fibroblasts assessed as inhibition of poly(I:C)-induced cytokine secretion at 3 uM preincubated for 3 hrs followed by poly(I:C) stimulation measured after 18 hrs by sandwich immunoassay	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(Oc4ccnc5[nH]ccc45)c3)cc2C(F)(F)F)CC1		CHEMBL4125960		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
	18276157	CHEMBL4119087	Inhibition of human TAK1 (1 to 303 residues) expressed in mammalian expression system assessed as enzyme activity at 10 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	3.6	CHEMBL5776	Homo sapiens	Activity	%	3.6
	18282729	CHEMBL4120314	Inhibition of c-TAK1 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	15.0	CHEMBL5776	Homo sapiens	INH	%	15.0
	18282956	CHEMBL4120541	Inhibition of c-TAK1 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	0.3	CHEMBL5776	Homo sapiens	INH	%	0.3
	18283180	CHEMBL4120765	Inhibition of c-TAK1 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	2.0	CHEMBL5776	Homo sapiens	INH	%	2.0
	18300346	CHEMBL4124648	Inhibition of full length recombinant human N-terminal His6-tagged TAK1 expressed in Escherichia coli assessed as residual activity at 1 uM relative to control	B	CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(N)c(C#N)c4)c3c2)n1		CHEMBL4126750	=	Activity	%	103.0	CHEMBL5776	Homo sapiens	Activity	%	103.0
	18379946	CHEMBL4145847	Inhibition of TAK1 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	-0.19	CHEMBL5776	Homo sapiens	INH	%	-0.19
	18379998	CHEMBL4145899	Inhibition of TAK1 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	43.11	CHEMBL5776	Homo sapiens	IC50	nM	43.11
	18440468	CHEMBL4157292	Binding affinity to wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL5776	Homo sapiens	Activity	%	100.0
	18443286	CHEMBL4157910	Inhibition of human TAK1 assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	62.0	CHEMBL5776	Homo sapiens	Activity	%	62.0
	18462203	CHEMBL4180890	Inhibition of TAK1 (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	Activity	%	86.0	CHEMBL5776	Homo sapiens	Activity	%	86.0
	18470589	CHEMBL4182583	Inhibition of human TAK1 at 10 uM by ADP-Glo kinase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	81.0	CHEMBL5776	Homo sapiens	INH	%	81.0
	18470769	CHEMBL4182583	Inhibition of human TAK1 at 10 uM by ADP-Glo kinase assay	B	Cc1nc(N)c2ccn(C3CCN(C(=O)c4ccc(S(=O)(=O)F)cc4)CC3)c2n1		CHEMBL4206295	=	Inhibition	%	52.0	CHEMBL5776	Homo sapiens	INH	%	52.0
	18470770	CHEMBL4182583	Inhibition of human TAK1 at 10 uM by ADP-Glo kinase assay	B	Nc1ncnc2c1ccn2C1CCN(C(=O)c2ccc(S(=O)(=O)F)cc2)CC1		CHEMBL4218073	=	Inhibition	%	9.0	CHEMBL5776	Homo sapiens	INH	%	9.0
	18484424	CHEMBL4186071	Binding affinity to wild-type human partial length TAK1 (M1 to Q303 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	96.0	CHEMBL5776	Homo sapiens	Activity	%	96.0
	18484908	CHEMBL4186071	Binding affinity to wild-type human partial length TAK1 (M1 to Q303 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	66.0	CHEMBL5776	Homo sapiens	Activity	%	66.0
	18507588	CHEMBL4191179	Inhibition of recombinant human TAK1 (1 to 303 residues) at 1 uM using casein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-3.0	CHEMBL5776	Homo sapiens	INH	%	-3.0
	18653341	CHEMBL4230235	Inhibition of TAK1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	62.0	CHEMBL5776	Homo sapiens	INH	%	62.0
	18653342	CHEMBL4230235	Inhibition of TAK1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	5.0	CHEMBL5776	Homo sapiens	INH	%	5.0
	18655264	CHEMBL4230971	Binding affinity to wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	92.0	CHEMBL5776	Homo sapiens	Activity	%	92.0
	18665455	CHEMBL4233414	Inhibition of TAK1 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	10000.0	CHEMBL5776	Homo sapiens	IC50	nM	10000.0
	18665464	CHEMBL4233414	Inhibition of TAK1 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4251324	>	IC50	nM	10000.0	CHEMBL5776	Homo sapiens	IC50	nM	10000.0
	18674916	CHEMBL4235441	Inhibition of TAK1 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	=	Ki	nM	2700.0	CHEMBL5776	Homo sapiens	Ki	nM	2700.0
Not Determined	18674917	CHEMBL4235441	Inhibition of TAK1 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242		Ki			CHEMBL5776	Homo sapiens	Ki		
	18674918	CHEMBL4235441	Inhibition of TAK1 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	4000.0	CHEMBL5776	Homo sapiens	Ki	nM	4000.0
	18697700	CHEMBL4254373	Inhibition of wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	76.0	CHEMBL5776	Homo sapiens	Activity	%	76.0
	18751248	CHEMBL4263957	Inhibition of TAK1 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	4.0	CHEMBL5776	Homo sapiens	INH	%	4.0
	18752223	CHEMBL4264560	Binding affinity to wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL5776	Homo sapiens	Activity	%	100.0
	18761585	CHEMBL4266636	Inhibition of recombinant human N-terminal His6-tagged TAK1 expressed in Escherichia coli at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	1.0	CHEMBL5776	Homo sapiens	INH	%	1.0
	18761856	CHEMBL4266636	Inhibition of recombinant human N-terminal His6-tagged TAK1 expressed in Escherichia coli at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	1.0	CHEMBL5776	Homo sapiens	INH	%	1.0
	18762019	CHEMBL4266636	Inhibition of recombinant human N-terminal His6-tagged TAK1 expressed in Escherichia coli at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	-4.0	CHEMBL5776	Homo sapiens	INH	%	-4.0
	18764659	CHEMBL4267122	Inhibition of human TAK1 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL5776	Homo sapiens	INH	%	70.0
	18764660	CHEMBL4267122	Inhibition of human TAK1 at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL5776	Homo sapiens	INH	%	70.0
	18764661	CHEMBL4267122	Inhibition of human TAK1 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL5776	Homo sapiens	INH	%	70.0
	18782865	CHEMBL4270731	Inhibition of TAK1 (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	>	Activity	%	80.0	CHEMBL5776	Homo sapiens	Activity	%	80.0
	18858223	CHEMBL4308069	Binding affinity to wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	78.0	CHEMBL5776	Homo sapiens	Activity	%	78.0
	18892982	CHEMBL4314948	Inhibition of human TAK1 (1 to 303 residues) using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	98.5	CHEMBL5776	Homo sapiens	Activity	%	98.5
	18919437	CHEMBL4322794	Binding affinity to recombinant full-length N-terminal His-FLAG-tagged MAP3K7 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	44.0	CHEMBL5776	Homo sapiens	Kd	nM	44.0
	18919625	CHEMBL4322794	Binding affinity to recombinant full-length N-terminal His-FLAG-tagged MAP3K7 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	60.0	CHEMBL5776	Homo sapiens	Kd	nM	60.0
	18938339	CHEMBL4327896	Inhibition of human TAK1 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	100.52	CHEMBL5776	Homo sapiens	Activity	%	100.52
	18938340	CHEMBL4327896	Inhibition of human TAK1 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	99.98	CHEMBL5776	Homo sapiens	Activity	%	99.98
	18938741	CHEMBL4328260	Inhibition of human TAK1 assessed as residual activity at 100 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5776	Homo sapiens	Activity	%	65.0
	18939127	CHEMBL4328624	Inhibition of human TAK1 using casein as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	66.2	CHEMBL5776	Homo sapiens	IC50	10'-8M	6.62
	18958995	CHEMBL4333651	Binding affinity to wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL5776	Homo sapiens	Activity	%	100.0
	18964731	CHEMBL4335307	Inhibition of human TAK1 (1 to 303 residues) assessed as residual activity at 1 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	92.0	CHEMBL5776	Homo sapiens	Activity	%	92.0
	18964732	CHEMBL4335307	Inhibition of human TAK1 (1 to 303 residues) assessed as residual activity at 1 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	100.0	CHEMBL5776	Homo sapiens	Activity	%	100.0
	18972121	CHEMBL4337131	Inhibition of recombinant human TAK1 (1 to 303 residues) assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	91.0	CHEMBL5776	Homo sapiens	Activity	%	91.0
	18976016	CHEMBL4338194	Inhibition of TAK1 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3oc(-c4ccc[nH]4)nc3I)c12		CHEMBL4555884	>	IC50	nM	10000.0	CHEMBL5776	Homo sapiens	IC50	uM	10.0
	18976017	CHEMBL4338194	Inhibition of TAK1 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc(Br)[nH]4)o3)c12		CHEMBL4475097	>	IC50	nM	10000.0	CHEMBL5776	Homo sapiens	IC50	uM	10.0
	18976018	CHEMBL4338194	Inhibition of TAK1 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	IC50	nM	1200.0	CHEMBL5776	Homo sapiens	IC50	uM	1.2
	18976019	CHEMBL4338194	Inhibition of TAK1 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc[nH]4)o3)c12		CHEMBL4446434	=	IC50	nM	1000.0	CHEMBL5776	Homo sapiens	IC50	uM	1.0
	18976020	CHEMBL4338194	Inhibition of TAK1 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4cc(Br)c[nH]4)o3)c12		CHEMBL4476426	=	IC50	nM	36000.0	CHEMBL5776	Homo sapiens	IC50	uM	36.0
	18976021	CHEMBL4338194	Inhibition of TAK1 (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]c(I)c(-c3cnc(-c4ccc[nH]4)o3)c12		CHEMBL4548361	=	IC50	nM	18000.0	CHEMBL5776	Homo sapiens	IC50	uM	18.0
	18976057	CHEMBL4338205	Inhibition of TAK1 (unknown origin) assessed as residual enzyme activity at 50 uM by [33P]-ATP filter binding kinase assay relative to control	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Activity	%	7.0	CHEMBL5776	Homo sapiens	Activity	%	7.0
	18976063	CHEMBL4338211	Inhibition of TAK1 (unknown origin) assessed as residual enzyme activity at 1 uM by [33P]-ATP filter binding kinase assay relative to control	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Activity	%	35.0	CHEMBL5776	Homo sapiens	Activity	%	35.0
	18976083	CHEMBL4338230	Binding affinity to wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by active-site directed competition binding assay based Kinomescan method relative to control	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Activity	%	70.0	CHEMBL5776	Homo sapiens	Activity	%	70.0
Not Active	19040179	CHEMBL4352080	Inhibition of human TAK1 (1 to 303 residues) using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Active	19041298	CHEMBL4352559	Inhibition of human TAK1 at 10 uM using casein as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
Not Determined	19059346	CHEMBL4357707	Inhibition of tracer 222 binding to recombinant human His-tagged TAK1 (437 to 504 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 60 mins by Lanthascreen assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1OCc1ccc(Oc2ccccc2)cc1		CHEMBL4569421		IC50			CHEMBL5776	Homo sapiens	IC50		
Not Determined	19059347	CHEMBL4357707	Inhibition of tracer 222 binding to recombinant human His-tagged TAK1 (437 to 504 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 60 mins by Lanthascreen assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1OCc1c(C)cccc1Cl		CHEMBL4462060		IC50			CHEMBL5776	Homo sapiens	IC50		
Not Determined	19059348	CHEMBL4357707	Inhibition of tracer 222 binding to recombinant human His-tagged TAK1 (437 to 504 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 60 mins by Lanthascreen assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1OCc1ccc(C)cc1		CHEMBL4460150		IC50			CHEMBL5776	Homo sapiens	IC50		
	19059349	CHEMBL4357707	Inhibition of tracer 222 binding to recombinant human His-tagged TAK1 (437 to 504 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 60 mins by Lanthascreen assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1-c1ccc(Oc2ccccc2)cc1		CHEMBL4442889	=	IC50	nM	5460.0	CHEMBL5776	Homo sapiens	IC50	nM	5460.0
	19059350	CHEMBL4357707	Inhibition of tracer 222 binding to recombinant human His-tagged TAK1 (437 to 504 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 60 mins by Lanthascreen assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1-c1ccc(C(C)=O)cc1		CHEMBL4562024	=	IC50	nM	1490.0	CHEMBL5776	Homo sapiens	IC50	nM	1490.0
	19059351	CHEMBL4357707	Inhibition of tracer 222 binding to recombinant human His-tagged TAK1 (437 to 504 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 60 mins by Lanthascreen assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1-c1ccc(OC)nc1		CHEMBL4563120	=	IC50	nM	1890.0	CHEMBL5776	Homo sapiens	IC50	nM	1890.0
	19059352	CHEMBL4357707	Inhibition of tracer 222 binding to recombinant human His-tagged TAK1 (437 to 504 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 60 mins by Lanthascreen assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1-c1ccoc1		CHEMBL4538743	=	IC50	nM	224.0	CHEMBL5776	Homo sapiens	IC50	nM	224.0
	19059353	CHEMBL4357707	Inhibition of tracer 222 binding to recombinant human His-tagged TAK1 (437 to 504 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 60 mins by Lanthascreen assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1-c1cccs1		CHEMBL4574265	=	IC50	nM	543.0	CHEMBL5776	Homo sapiens	IC50	nM	543.0
	19059354	CHEMBL4357707	Inhibition of tracer 222 binding to recombinant human His-tagged TAK1 (437 to 504 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 60 mins by Lanthascreen assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	IC50	nM	50.0	CHEMBL5776	Homo sapiens	IC50	nM	50.0
	19059848	CHEMBL4358149	Binding affinity to wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	99.0	CHEMBL5776	Homo sapiens	Activity	%	99.0
	19090412	CHEMBL4365986	Inhibition of wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL5776	Homo sapiens	Activity	%	100.0
	19092135	CHEMBL4366609	Inhibition of human TAK1 at 100 nM using casein as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	12.48	CHEMBL5776	Homo sapiens	INH	%	12.48
	19144905	CHEMBL4377921	Inhibition of human TAK1 (1 to 303 residues) at 1 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	79.0	CHEMBL5776	Homo sapiens	INH	%	79.0
	19146979	CHEMBL4378813	Inhibition of recombinant human TAK1 (1 to 303 residues) at 10 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	5.0	CHEMBL5776	Homo sapiens	INH	%	5.0
	19148058	CHEMBL4379454	Inhibition of recombinant human TAK1 (1 to 303 residues) using casein as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5776	Homo sapiens	IC50	uM	10.0
	19159676	CHEMBL4382780	Binding affinity to wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	35.0	CHEMBL5776	Homo sapiens	Activity	%	35.0
	19191331	CHEMBL4389499	Inhibition of wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	24.0	CHEMBL5776	Homo sapiens	INH	%	24.0
	19192162	CHEMBL4389976	Inhibition of wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	97.0	CHEMBL5776	Homo sapiens	INH	%	97.0
	19200418	CHEMBL4391602	Binding affinity to wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	1.6	CHEMBL5776	Homo sapiens	Activity	%	1.6
	19242755	CHEMBL4400090	Inhibition of recombinant human TAK1 (1 to 303 residues) assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	66.0	CHEMBL5776	Homo sapiens	Activity	%	66.0
	19266634	CHEMBL4405584	Inhibition of wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5776	Homo sapiens	INH	%	50.0
	19276144	CHEMBL4408147	Inhibition of recombinant human TAK1 (1 to 303 residues) at 1 uM using casein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	7.0	CHEMBL5776	Homo sapiens	INH	%	7.0
	19296271	CHEMBL4412492	Inhibition of recombinant FLAG-tagged TAK1 (unknown origin) co-expressed with TAB (unknown origin) in baculovirus using BT-MKK as substrate after 1 hr by AlphaScreen assay	B	CCc1cc(Nc2ncc(F)c(-c3cnc4cccnn34)n2)cc(OCCN2CCC(O)CC2)c1		CHEMBL3823303	=	IC50	nM	8.0	CHEMBL5776	Homo sapiens	IC50	nM	8.0
	19296272	CHEMBL4412493	Inhibition of TAK1 (unknown origin)	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(C#N)c2)ccc1Oc1ccncc1		CHEMBL3822835	=	IC50	nM	156.0	CHEMBL5776	Homo sapiens	IC50	nM	156.0
	19296273	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	CCc1cc(Nc2ncc(F)c(-c3cnc4cccnn34)n2)cc(OCCN2CCC(O)CC2)c1		CHEMBL3823303	=	Inhibition	%	98.0	CHEMBL5776	Homo sapiens	INH	%	98.0
	19296274	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1ccc(C(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1Oc1cnc(NC2CC2)c2nccn12		CHEMBL4468493	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	19296275	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(C(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)ccc1Oc1cnc(NC2CC2)c2nccn12		CHEMBL4574606	=	Inhibition	%	3.0	CHEMBL5776	Homo sapiens	INH	%	3.0
	19296276	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)ccc1Oc1cn2ccnc2c(NC2CC2)n1		CHEMBL4444643	=	Inhibition	%	30.0	CHEMBL5776	Homo sapiens	INH	%	30.0
	19296277	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)ccc1Oc1cnc(NC2CC2)c2nccn12		CHEMBL4529499	=	Inhibition	%	90.0	CHEMBL5776	Homo sapiens	INH	%	90.0
	19296278	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(C#N)c2)ccc1Oc1cnc(NC2CC2)c2nccn12		CHEMBL4526846	=	Inhibition	%	76.0	CHEMBL5776	Homo sapiens	INH	%	76.0
	19296279	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4586372	=	Inhibition	%	98.0	CHEMBL5776	Homo sapiens	INH	%	98.0
	19296280	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(F)c2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4518128	=	Inhibition	%	94.0	CHEMBL5776	Homo sapiens	INH	%	94.0
	19296281	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(Cl)c2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4436013	=	Inhibition	%	84.0	CHEMBL5776	Homo sapiens	INH	%	84.0
	19296282	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(C#N)c2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4535889	=	Inhibition	%	97.0	CHEMBL5776	Homo sapiens	INH	%	97.0
	19296283	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(F)cc2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4552889	=	Inhibition	%	69.0	CHEMBL5776	Homo sapiens	INH	%	69.0
	19296284	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(C#N)cc2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4470058	=	Inhibition	%	84.0	CHEMBL5776	Homo sapiens	INH	%	84.0
	19296285	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cnc(NC4CC4)c4nccn34)c(C)c2)cc1		CHEMBL4540491	=	Inhibition	%	91.0	CHEMBL5776	Homo sapiens	INH	%	91.0
	19296286	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccnc2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4591670	=	Inhibition	%	89.0	CHEMBL5776	Homo sapiens	INH	%	89.0
	19296287	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)ccc1-c1cnc(NC2CC2)c2ncnn12		CHEMBL4471413	=	Inhibition	%	80.0	CHEMBL5776	Homo sapiens	INH	%	80.0
	19296288	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc([N+](=O)[O-])c2)ccc1-c1cnc(NC2CC2)c2ncnn12		CHEMBL4456854	=	Inhibition	%	90.0	CHEMBL5776	Homo sapiens	INH	%	90.0
	19296289	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(Cl)c2)ccc1-c1cnc(NC2CC2)c2ncnn12		CHEMBL4475871	=	Inhibition	%	74.0	CHEMBL5776	Homo sapiens	INH	%	74.0
	19296290	CHEMBL4412494	Inhibition of TAK1 (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(C#N)c2)ccc1-c1cnc(NC2CC2)c2ncnn12		CHEMBL4475202	=	Inhibition	%	92.0	CHEMBL5776	Homo sapiens	INH	%	92.0
	19296291	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	CCc1cc(Nc2ncc(F)c(-c3cnc4cccnn34)n2)cc(OCCN2CCC(O)CC2)c1		CHEMBL3823303	=	Inhibition	%	96.0	CHEMBL5776	Homo sapiens	INH	%	96.0
	19296292	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1ccc(C(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1Oc1cnc(NC2CC2)c2nccn12		CHEMBL4468493	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	19296293	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(C(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)ccc1Oc1cnc(NC2CC2)c2nccn12		CHEMBL4574606	=	Inhibition	%	4.0	CHEMBL5776	Homo sapiens	INH	%	4.0
	19296294	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)ccc1Oc1cn2ccnc2c(NC2CC2)n1		CHEMBL4444643	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	19296295	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)ccc1Oc1cnc(NC2CC2)c2nccn12		CHEMBL4529499	=	Inhibition	%	20.0	CHEMBL5776	Homo sapiens	INH	%	20.0
	19296296	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(C#N)c2)ccc1Oc1cnc(NC2CC2)c2nccn12		CHEMBL4526846	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	19296297	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4586372	=	Inhibition	%	56.0	CHEMBL5776	Homo sapiens	INH	%	56.0
	19296298	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(F)c2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4518128	=	Inhibition	%	34.0	CHEMBL5776	Homo sapiens	INH	%	34.0
	19296299	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(Cl)c2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4436013	=	Inhibition	%	16.0	CHEMBL5776	Homo sapiens	INH	%	16.0
	19296300	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(C#N)c2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4535889	=	Inhibition	%	49.0	CHEMBL5776	Homo sapiens	INH	%	49.0
	19296301	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(F)cc2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4552889	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	19296302	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccc(C#N)cc2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4470058	=	Inhibition	%	19.0	CHEMBL5776	Homo sapiens	INH	%	19.0
	19296303	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cnc(NC4CC4)c4nccn34)c(C)c2)cc1		CHEMBL4540491	=	Inhibition	%	7.0	CHEMBL5776	Homo sapiens	INH	%	7.0
	19296304	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccnc2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4591670	=	Inhibition	%	43.0	CHEMBL5776	Homo sapiens	INH	%	43.0
	19296305	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)ccc1-c1cnc(NC2CC2)c2ncnn12		CHEMBL4471413	=	Inhibition	%	24.0	CHEMBL5776	Homo sapiens	INH	%	24.0
	19296306	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc([N+](=O)[O-])c2)ccc1-c1cnc(NC2CC2)c2ncnn12		CHEMBL4456854	=	Inhibition	%	26.0	CHEMBL5776	Homo sapiens	INH	%	26.0
	19296307	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(Cl)c2)ccc1-c1cnc(NC2CC2)c2ncnn12		CHEMBL4475871	=	Inhibition	%	18.0	CHEMBL5776	Homo sapiens	INH	%	18.0
	19296308	CHEMBL4412495	Inhibition of TAK1 (unknown origin) at 0.1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2cccc(C#N)c2)ccc1-c1cnc(NC2CC2)c2ncnn12		CHEMBL4475202	=	Inhibition	%	36.0	CHEMBL5776	Homo sapiens	INH	%	36.0
Dose-dependent effect	19296320	CHEMBL4412500	Inhibition of TAK1 phosphorylation in human SW620 cells after 24 hrs by immunoblotting analysis	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4586372		Inhibition	%		CHEMBL5776	Homo sapiens	INH		
	20691803	CHEMBL4625643	Inhibition of human wild type partial length TAK1 (1 to 303 residues) expressed in mammalian expression system	A	CC(C)Nc1cc(Nc2ccn3nccc3n2)ncc1C(=O)NC[C@@H](F)C(C)(C)O		CHEMBL4641090	=	IC50	nM	190.0	CHEMBL5776	Homo sapiens	IC50	nM	190.0
	20714342	CHEMBL4629867	Binding affinity to wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	NC(=O)c1cnc(N2CCC[C@H](N)C2)nc1Nc1cccc(C(F)(F)F)c1		CHEMBL1835063	=	Activity	%	5.7	CHEMBL5776	Homo sapiens	Activity	%	5.7
	20714369	CHEMBL4629878	Inhibition of human TAK1 using casein as substrate in presence of [gamma-33P]-ATP by hotspot kinase assay	B	NC(=O)c1cnc(N2CCC[C@H](N)C2)nc1Nc1cccc(C(F)(F)F)c1		CHEMBL1835063	=	IC50	nM	356.0	CHEMBL5776	Homo sapiens	IC50	uM	0.356
	22423203	CHEMBL4674177	Inhibition of human TAK1 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	97.97	CHEMBL5776	Homo sapiens	Activity	%	97.97
	22423204	CHEMBL4674177	Inhibition of human TAK1 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	17.28	CHEMBL5776	Homo sapiens	Activity	%	17.28
	22479186	CHEMBL4686917	Inhibition of TAK1 (unknown origin)	B	Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1		CHEMBL3916717	>	IC50	nM	10000.0	CHEMBL5776	Homo sapiens	IC50	uM	10.0
	22479187	CHEMBL4686917	Inhibition of TAK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ccccn2)n1		CHEMBL4776637	=	IC50	nM	734.4	CHEMBL5776	Homo sapiens	IC50	nM	734.4
	22479188	CHEMBL4686917	Inhibition of TAK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ccc(-c3ccn(C)n3)cn2)n1		CHEMBL4744931	=	IC50	nM	2224.0	CHEMBL5776	Homo sapiens	IC50	nM	2224.0
	22479189	CHEMBL4686917	Inhibition of TAK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2nccc3ccccc23)n1		CHEMBL4763562	=	IC50	nM	85.2	CHEMBL5776	Homo sapiens	IC50	nM	85.2
	22479190	CHEMBL4686917	Inhibition of TAK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2cc3ccccc3cn2)n1		CHEMBL4749551	=	IC50	nM	1359.0	CHEMBL5776	Homo sapiens	IC50	nM	1359.0
	22479191	CHEMBL4686917	Inhibition of TAK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ccc3ccccc3n2)n1		CHEMBL4795965	=	IC50	nM	4564.0	CHEMBL5776	Homo sapiens	IC50	nM	4564.0
	22479192	CHEMBL4686917	Inhibition of TAK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ncnc3ccccc23)n1		CHEMBL4751918	=	IC50	nM	421.2	CHEMBL5776	Homo sapiens	IC50	nM	421.2
	22479193	CHEMBL4686917	Inhibition of TAK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2cnc3ccccc3n2)n1		CHEMBL4778358	=	IC50	nM	6801.0	CHEMBL5776	Homo sapiens	IC50	nM	6801.0
	22479194	CHEMBL4686917	Inhibition of TAK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ncc3ccccc3n2)n1		CHEMBL4750857	=	IC50	nM	4221.0	CHEMBL5776	Homo sapiens	IC50	nM	4221.0
	22479195	CHEMBL4686917	Inhibition of TAK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2ncc3[nH]cnc3n2)n1		CHEMBL4759182	=	IC50	nM	1207.0	CHEMBL5776	Homo sapiens	IC50	nM	1207.0
	22479196	CHEMBL4686917	Inhibition of TAK1 (unknown origin)	B	CC(C)n1cnnc1-c1cccc(NC(=O)Nc2cc3ccccn3n2)n1		CHEMBL4740051	>	IC50	nM	10000.0	CHEMBL5776	Homo sapiens	IC50	uM	10.0
	22479197	CHEMBL4686917	Inhibition of TAK1 (unknown origin)	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2nccc3ccccc23)n1		CHEMBL4764071	=	IC50	nM	63.7	CHEMBL5776	Homo sapiens	IC50	nM	63.7
	22479198	CHEMBL4686917	Inhibition of TAK1 (unknown origin)	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2ccc3ccccc3n2)n1		CHEMBL4753203	=	IC50	nM	1883.0	CHEMBL5776	Homo sapiens	IC50	nM	1883.0
	22479199	CHEMBL4686917	Inhibition of TAK1 (unknown origin)	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2cnc3ccccc3n2)n1		CHEMBL4761865	>	IC50	nM	10000.0	CHEMBL5776	Homo sapiens	IC50	uM	10.0
	22479200	CHEMBL4686917	Inhibition of TAK1 (unknown origin)	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2ncc3ccccc3n2)n1		CHEMBL4752034	=	IC50	nM	5769.0	CHEMBL5776	Homo sapiens	IC50	nM	5769.0
	22479201	CHEMBL4686917	Inhibition of TAK1 (unknown origin)	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2cc3ccccn3n2)n1		CHEMBL4796925	=	IC50	nM	4976.0	CHEMBL5776	Homo sapiens	IC50	nM	4976.0
	22479244	CHEMBL4686934	Inhibition of human recombinant TAK1 (1 to 303 residues) assessed as residual activity using casein as substrate at 1 uM incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2cc3ccccn3n2)n1		CHEMBL4796925	=	Activity	%	25.0	CHEMBL5776	Homo sapiens	Activity	%	25.0
	22752659	CHEMBL4700136	Inhibition of human TAK1 by kinase-profiling analysis	B	C#Cc1nc(Nc2cccc(CC(N)=O)c2)nc2[nH]cnc12		CHEMBL4786783	=	IC50	nM	240.0	CHEMBL5776	Homo sapiens	IC50	uM	0.24
	22809768	CHEMBL4713303	Inhibition of recombinant human TAK1 (1 to 303 residues) assessed as residual activity at 1 uM using casein as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	88.0	CHEMBL5776	Homo sapiens	Activity	%	88.0
	22815881	CHEMBL4714733	Binding affinity to wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system by Kinomescan method	B	CNC(=O)CN(Cc1ccccc1OC(F)F)C(=O)c1c[nH]c(C(=O)N2CCCC2)n1		CHEMBL4779479	=	Kd	nM	55.0	CHEMBL5776	Homo sapiens	Kd	nM	55.0
	22820584	CHEMBL4716294	Inhibition of human TAK1 assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	104.0	CHEMBL5776	Homo sapiens	Activity	%	104.0
	22820585	CHEMBL4716294	Inhibition of human TAK1 assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	87.0	CHEMBL5776	Homo sapiens	Activity	%	87.0
	22843246	CHEMBL4720260	Inhibition of recombinant human TAK1 using Ulight-FLGFTYVAP as substrate incubate for 90 mins by LANCE assay	B	C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1		CHEMBL4755698	>	IC50	nM	10000.0	CHEMBL5776	Homo sapiens	IC50	nM	10000.0
	22843549	CHEMBL4720535	Inhibition of human TAK1 using casein as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	99.0	CHEMBL5776	Homo sapiens	IC50	10^-8M	9.9
	22843892	CHEMBL4720878	Inhibition of human TAK1 assessed as residual activity using casein as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	97.41	CHEMBL5776	Homo sapiens	Activity	%	97.41
	22844876	CHEMBL4721551	Inhibition of wild-type human partial length TAK1 (M1 to Q303 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	87.46	CHEMBL5776	Homo sapiens	Activity	%	87.46
	22949240	CHEMBL4765767	Inhibition of human MAP3K7 assessed as residual activity at 0.1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	104.0	CHEMBL5776	Homo sapiens	Activity	%	104.0
	22949241	CHEMBL4765767	Inhibition of human MAP3K7 assessed as residual activity at 0.1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	101.0	CHEMBL5776	Homo sapiens	Activity	%	101.0
	22949242	CHEMBL4765767	Inhibition of human MAP3K7 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	106.0	CHEMBL5776	Homo sapiens	Activity	%	106.0
	22949243	CHEMBL4765767	Inhibition of human MAP3K7 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	93.0	CHEMBL5776	Homo sapiens	Activity	%	93.0
	22949244	CHEMBL4765767	Inhibition of human MAP3K7 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	93.0	CHEMBL5776	Homo sapiens	Activity	%	93.0
	22949245	CHEMBL4765767	Inhibition of human MAP3K7 assessed as residual activity at 0.1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	85.0	CHEMBL5776	Homo sapiens	Activity	%	85.0
	22949246	CHEMBL4765768	Inhibition of human MAP3K7 assessed as residual activity at 1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	95.0	CHEMBL5776	Homo sapiens	Activity	%	95.0
	22949247	CHEMBL4765768	Inhibition of human MAP3K7 assessed as residual activity at 1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	92.0	CHEMBL5776	Homo sapiens	Activity	%	92.0
	22949248	CHEMBL4765768	Inhibition of human MAP3K7 assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	88.0	CHEMBL5776	Homo sapiens	Activity	%	88.0
	22949249	CHEMBL4765768	Inhibition of human MAP3K7 assessed as residual activity at 1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	64.0	CHEMBL5776	Homo sapiens	Activity	%	64.0
	22949250	CHEMBL4765768	Inhibition of human MAP3K7 assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	89.0	CHEMBL5776	Homo sapiens	Activity	%	89.0
	22949251	CHEMBL4765768	Inhibition of human MAP3K7 assessed as residual activity at 1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	63.0	CHEMBL5776	Homo sapiens	Activity	%	63.0
	22950609	CHEMBL4766176	Inhibition of human recombinant TAK1 (1 to 313 residues) using casein as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	50.0	CHEMBL5776	Homo sapiens	IC50	uM	0.05
	22953011	CHEMBL4766948	Inhibition of recombinant human TAK1 (1 to 303 residues) assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	5.0	CHEMBL5776	Homo sapiens	Activity	%	5.0
	22953101	CHEMBL4767038	Inhibition of recombinant human TAK1 (1 to 303 residues) using casein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	484.0	CHEMBL5776	Homo sapiens	IC50	uM	0.484
	23122396	CHEMBL4804759	Inhibition of TAK1 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	39100.0	CHEMBL5776	Homo sapiens	IC50	uM	39.1
	23122397	CHEMBL4804759	Inhibition of TAK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	30000.0	CHEMBL5776	Homo sapiens	IC50	uM	30.0
	23122398	CHEMBL4804759	Inhibition of TAK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	35000.0	CHEMBL5776	Homo sapiens	IC50	uM	35.0
	23122399	CHEMBL4804760	Inhibition of TAK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	35.0	CHEMBL5776	Homo sapiens	INH	%	35.0
	23122400	CHEMBL4804760	Inhibition of TAK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL5776	Homo sapiens	INH	%	0.0
	23122401	CHEMBL4804760	Inhibition of TAK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	35.0	CHEMBL5776	Homo sapiens	INH	%	35.0
	23213429	CHEMBL4822963	Inhibition of human recombinant MAP3K7 by Lanthascreen assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	21.0	CHEMBL5776	Homo sapiens	INH	%	21.0
Not Active	23317669	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	81.0	CHEMBL5776	Homo sapiens	% Control	%	81.0
Not Active	23318137	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	99.0	CHEMBL5776	Homo sapiens	% Control	%	99.0
Not Active	23318803	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23319287	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	67.0	CHEMBL5776	Homo sapiens	% Control	%	67.0
Not Active	23319923	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	85.5	CHEMBL5776	Homo sapiens	% Control	%	85.5
Not Active	23320399	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	84.7	CHEMBL5776	Homo sapiens	% Control	%	84.7
Not Active	23321077	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	52.0	CHEMBL5776	Homo sapiens	% Control	%	52.0
Not Active	23321545	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	74.0	CHEMBL5776	Homo sapiens	% Control	%	74.0
Not Active	23322175	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23322643	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	97.0	CHEMBL5776	Homo sapiens	% Control	%	97.0
Not Active	23323332	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23323800	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23324143	CHEMBL4880761	TAK1 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1	Outside typical range	CHEMBL4593677		Inhibition	%	-12.0	CHEMBL5776	Homo sapiens	% inhibition	%	-12.0
Not Active	23324654	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23325289	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23325757	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	86.0	CHEMBL5776	Homo sapiens	% Control	%	86.0
Not Active	23326404	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	75.0	CHEMBL5776	Homo sapiens	% Control	%	75.0
Not Active	23326872	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	98.0	CHEMBL5776	Homo sapiens	% Control	%	98.0
Not Active	23327572	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	80.0	CHEMBL5776	Homo sapiens	% Control	%	80.0
Not Active	23328040	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	63.0	CHEMBL5776	Homo sapiens	% Control	%	63.0
Not Active	23328627	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	68.0	CHEMBL5776	Homo sapiens	% Control	%	68.0
Not Active	23329095	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23329544	CHEMBL4881251	TAK1(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	107.0	CHEMBL5776	Homo sapiens	% residual kinase activity	%	107.0
Not Active	23330041	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23330509	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23331265	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23331733	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23332320	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	66.2	CHEMBL5776	Homo sapiens	% Control	%	66.2
Not Active	23332786	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23333504	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23334143	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	70.0	CHEMBL5776	Homo sapiens	% Control	%	70.0
Not Active	23334611	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	75.0	CHEMBL5776	Homo sapiens	% Control	%	75.0
Not Active	23335590	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	92.0	CHEMBL5776	Homo sapiens	% Control	%	92.0
Not Active	23336058	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23336685	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	94.0	CHEMBL5776	Homo sapiens	% Control	%	94.0
Not Active	23337153	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	75.0	CHEMBL5776	Homo sapiens	% Control	%	75.0
Not Active	23337656	CHEMBL4882027	MAP3K7_K7IP1 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	87.0	CHEMBL5776	Homo sapiens	% Ctrl	%	87.0
Not Active	23338234	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	50.0	CHEMBL5776	Homo sapiens	% Control	%	50.0
Not Active	23338702	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	72.0	CHEMBL5776	Homo sapiens	% Control	%	72.0
Not Active	23339314	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23339782	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	92.0	CHEMBL5776	Homo sapiens	% Control	%	92.0
Not Active	23340419	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	94.0	CHEMBL5776	Homo sapiens	% Control	%	94.0
Not Active	23340887	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23341544	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23342012	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23342628	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	86.0	CHEMBL5776	Homo sapiens	% Control	%	86.0
Not Active	23343096	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23343726	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	80.0	CHEMBL5776	Homo sapiens	% Control	%	80.0
Not Active	23344194	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	95.0	CHEMBL5776	Homo sapiens	% Control	%	95.0
Not Active	23344832	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	90.0	CHEMBL5776	Homo sapiens	% Control	%	90.0
Not Active	23345405	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	67.0	CHEMBL5776	Homo sapiens	% Control	%	67.0
Not Active	23345873	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	77.0	CHEMBL5776	Homo sapiens	% Control	%	77.0
Not Active	23346449	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23346918	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	92.6	CHEMBL5776	Homo sapiens	% Control	%	92.6
Not Active	23347518	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	82.6	CHEMBL5776	Homo sapiens	% Control	%	82.6
Not Active	23348010	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23348589	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23349057	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	83.0	CHEMBL5776	Homo sapiens	% Control	%	83.0
Not Active	23349644	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23350262	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23350730	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	86.0	CHEMBL5776	Homo sapiens	% Control	%	86.0
Not Active	23351335	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23351803	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23352108	CHEMBL4882797	MAP3K7/MAP3K7IP1 (TAK1-TAB1) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-4.423	CHEMBL5776	Homo sapiens	% Inhibition	%	-4.4232
Not Active	23352827	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	70.0	CHEMBL5776	Homo sapiens	% Control	%	70.0
Not Active	23353295	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	89.0	CHEMBL5776	Homo sapiens	% Control	%	89.0
Not Active	23354177	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23354645	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23355377	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	93.0	CHEMBL5776	Homo sapiens	% Control	%	93.0
Not Active	23355845	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	78.0	CHEMBL5776	Homo sapiens	% Control	%	78.0
Not Active	23356481	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23356949	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23357558	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23358205	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23358673	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	93.0	CHEMBL5776	Homo sapiens	% Control	%	93.0
Not Active	23359259	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	60.2	CHEMBL5776	Homo sapiens	% Control	%	60.2
Not Active	23359857	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	77.0	CHEMBL5776	Homo sapiens	% Control	%	77.0
Not Active	23360325	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23360910	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	79.0	CHEMBL5776	Homo sapiens	% Control	%	79.0
Not Active	23361378	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23361951	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	89.0	CHEMBL5776	Homo sapiens	% Control	%	89.0
Not Active	23362487	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23362955	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	93.0	CHEMBL5776	Homo sapiens	% Control	%	93.0
Not Active	23364597	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23365065	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23365804	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23366347	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23366937	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
Not Active	23367405	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	89.0	CHEMBL5776	Homo sapiens	% Control	%	89.0
Not Active	23367625	CHEMBL4883978	MAP3K7/MAP3K7IP1 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	80.0	CHEMBL5776	Homo sapiens	% Residual activity with Skepinone-L	%	80.0
Not Active	23368283	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	90.0	CHEMBL5776	Homo sapiens	% Control	%	90.0
Not Active	23368751	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	89.0	CHEMBL5776	Homo sapiens	% Control	%	89.0
Not Active	23369350	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	85.0	CHEMBL5776	Homo sapiens	% Control	%	85.0
Not Active	23369818	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	74.0	CHEMBL5776	Homo sapiens	% Control	%	74.0
Not Active	23370254	CHEMBL4884493	TAK1(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	104.0	CHEMBL5776	Homo sapiens	% residual kinase activity	%	104.0
Not Active	23370786	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	92.0	CHEMBL5776	Homo sapiens	% Control	%	92.0
Not Active	23371254	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	74.0	CHEMBL5776	Homo sapiens	% Control	%	74.0
Not Active	23372063	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	94.0	CHEMBL5776	Homo sapiens	% Control	%	94.0
Not Active	23372531	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL5776	Homo sapiens	% Control	%	100.0
	23372786	CHEMBL4884751	MAP3K7(M315LGP1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5776	Homo sapiens	pIC50		6.0
	23372788	CHEMBL4884753	TAK1(M3K7CHY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5776	Homo sapiens	pIC50		6.0
	23373195	CHEMBL4885042	MAP3K7(M315LGP1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5776	Homo sapiens	pIC50		6.0
	23373197	CHEMBL4885044	TAK1(M3K7CHY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5776	Homo sapiens	pIC50		6.0
	23373555	CHEMBL4885332	MAP3K7(M315LGP1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5776	Homo sapiens	pIC50		6.0
	23373557	CHEMBL4885334	TAK1(M3K7CHY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5776	Homo sapiens	pIC50		6.0
Not Active	23375309	CHEMBL4886291	mitogen-activated protein kinase kinase kinase 7  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	5.0	CHEMBL5776	Homo sapiens	% inhibition	%	5.0
Not Active	23375958	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	95.0	CHEMBL5776	Homo sapiens	% Control	%	95.0
Not Active	23376426	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	90.0	CHEMBL5776	Homo sapiens	% Control	%	90.0
Not Active	23377003	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	78.0	CHEMBL5776	Homo sapiens	% Control	%	78.0
Not Active	23377471	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	99.0	CHEMBL5776	Homo sapiens	% Control	%	99.0
Not Active	23378331	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	77.0	CHEMBL5776	Homo sapiens	% Control	%	77.0
Not Active	23378799	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	81.0	CHEMBL5776	Homo sapiens	% Control	%	81.0
Not Active	23379966	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	90.0	CHEMBL5776	Homo sapiens	% Control	%	90.0
Not Active	23380434	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	99.0	CHEMBL5776	Homo sapiens	% Control	%	99.0
Not Active	23381128	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	96.0	CHEMBL5776	Homo sapiens	% Control	%	96.0
Not Active	23381776	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	97.0	CHEMBL5776	Homo sapiens	% Control	%	97.0
Not Active	23382244	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	96.0	CHEMBL5776	Homo sapiens	% Control	%	96.0
Not Active	23382868	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	57.0	CHEMBL5776	Homo sapiens	% Control	%	57.0
Slightly Active	23383336	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	48.0	CHEMBL5776	Homo sapiens	% Control	%	48.0
Not Active	23383857	CHEMBL4887481	MAP3K7_K7IP1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	101.0	CHEMBL5776	Homo sapiens	% Ctrl	%	101.0
Not Active	23384482	CHEMBL4888077	TAK1(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	7.89	CHEMBL5776	Homo sapiens	% inhibition	%	7.89
Not Active	23385251	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	89.0	CHEMBL5776	Homo sapiens	% Control	%	89.0
Not Active	23385718	CHEMBL4879975	KinomeScan assay: inhibition of TAK1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	84.0	CHEMBL5776	Homo sapiens	% Control	%	84.0
